ketoconazole has been researched along with Candidiasis in 352 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Candidiasis: Infection with a fungus of the genus CANDIDA. It is usually a superficial infection of the moist areas of the body and is generally caused by CANDIDA ALBICANS. (Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "This randomized comparative study assessed the efficacy and safety of a 10-mg once-daily topical regimen of miconazole nitrate mucoadhesive buccal tablet (n = 178) versus a 400-mg once-daily systemic regimen of ketoconazole (n = 179) in HIV-positive patients with oropharyngeal candidiasis." | 9.11 | Comparative efficacy of topical therapy with a slow-release mucoadhesive buccal tablet containing miconazole nitrate versus systemic therapy with ketoconazole in HIV-positive patients with oropharyngeal candidiasis. ( Haxaire, M; Kamya, M; Katabira, E; Lwanga, I; Van Roey, J, 2004) |
| "To evaluate the effectiveness of the combination of ketoconazol 400 mg + clindamycin 100 mg for 6 days compared to ketoconazol 800 mg + clindamycin 100 mg in Candida vaginitis and bacterial vaginosis." | 9.11 | [Comparison of efficacy of combination of ketokonazol 400 mg + clindamycin 100 mg with ketokonazol 800 mg + clindamycin 100 mg in the treatment of vaginitis due to Candida and bacterial vaginosis]. ( Garibay, M; Godínez, V; Mirabent, F; Pérez Calderón, A, 2005) |
| "To determine the clinical and endoscopic response of candida esophagitis to antifungal therapy and to compare the two oral antifungal agents, fluconazole and ketoconazole." | 9.07 | Fluconazole compared with ketoconazole for the treatment of Candida esophagitis in AIDS. A randomized trial. ( Conteas, CN; Dretler, RH; Islam, MZ; Koster, FM; Laine, L; Sattler, F; Squires, K; Tuazon, C, 1992) |
| "Long-term results of initial ketoconazole treatment were evaluated in 13 patients with chronic mucocutaneous candidiasis followed up for 3 years." | 9.06 | Ketoconazole treatment of 13 patients with chronic mucocutaneous candidiasis. A prospective 3-year trial. ( Mobacken, H; Moberg, S, 1986) |
| "The authors present the use of ketoconazole in 27 cases of paracoccidioidomycosis, eight of mycetoma, seven of chromomycosis, four of systemic candidiasis and one of lobomycosis." | 9.05 | Treatment of paracoccidioidomycosis, candidiasis, chromomycosis, lobomycosis, and mycetoma with ketoconazole. ( Cucé, LC; Sampaio, SA; Wroclawski, EL, 1980) |
| "Ketoconazole, a new oral antifungal agent, was evaluated in the treatment of four patients with severe chronic mucocutaneous candidiasis refractory to standard antifungal therapy." | 9.05 | Successful treatment of chronic mucocutaneous candidiasis with ketoconazole. ( Ament, ME; Byrne, W; Graybill, J; Rosenblatt, HM; Stiehm, ER, 1980) |
| "Twelve patients with chronic mucocutaneous candidiasis were assigned by random allocation to a 6-month course of treatment with ketoconazole or placebo in a double-blind trial." | 9.05 | Treatment of chronic mucocutaneous candidiasis with ketoconazole: a controlled clinical trial. ( Alling, DW; Kirkpatrick, CH; Petersen, EA, 1980) |
| "A multicenter double-blind study was conducted on the use of ketoconazole and griseofulvin for the treatment of dermatomycoses." | 9.05 | A multicenter double-blind evaluation of ketoconazole in the treatment of dermatomycoses. ( Daily, AD; Glogau, R; Jolly, HW; Krupp, I; Rex, IH; Stegman, SJ; Tromovitch, TA, 1983) |
| "Itraconazole and fluconazole are two relatively new anti-fungal agents which are being used successfully in the treatment of oropharyngeal candidiasis." | 8.78 | Itraconazole and fluconazole in oropharyngeal candidiasis. ( Arendorf, TM; van der Bijl, P, 1993) |
| " The case of a patient with environmental illness and systemic candidiasis for six weeks with ketoconazole, liver enzyme concentrations increased." | 8.78 | Ketoconazole hepatotoxicity in a patient treated for environmental illness and systemic candidiasis. ( Brusko, CS; Marten, JT, 1991) |
| "Esophageal candidiasis was diagnosed at endoscopy in two patients receiving omeprazole therapy." | 7.69 | Esophageal candidiasis following omeprazole therapy: a report of two cases. ( Chawla, LS; Jain, NP; Kumar, R; Sharma, M; Sood, A, 1995) |
| "In our study 77 AIDS patients suffering from oral and/or esophageal candidiasis were evaluated: 38 received fluconazole, 39 ketoconazole." | 7.68 | Fluconazole and ketoconazole in the treatment of oral and esophageal candidiasis in AIDS patients. ( Ancarani, F; Arzeni, D; Barchiesi, F; Branchesi, P; Crescenzi, G; Giacometti, A; Scalise, G, 1992) |
| " Itraconazole was superior to fluconazole in candidosis, cryptococcosis, sporotrichosis and aspergillosis, and to amphotericin B and to flucytosine in candidosis, cryptococcosis and aspergillosis." | 7.68 | In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents. ( Van Cutsem, J, 1992) |
| "The management of a preterm neonate with systemic candidiasis using oral itraconazole is described." | 7.68 | Itraconazole therapy for disseminated candidiasis in a very low birthweight neonate. ( Bhakoo, ON; Bhandari, V; Kumar, B; Nair, PM; Narang, A; Singh, M, 1992) |
| "We have treated 48 cases of onychomycosis (of which 37 were caused by dermatophytes, 10 by yeasts and one by Scopulariopsis brevicaulis) with 200 mg ketoconazole daily." | 7.67 | [Ketoconazole and onychomycosis]. ( Achten, G; André, J; Parent, D; Wiame, L, 1984) |
| "Oral ketoconazole (100 mg daily for 3 weeks) markedly reduced the severity of experimental Candida albicans keratitis in a group of 10 rabbits." | 7.67 | Oral ketoconazole therapy for experimental candida albicans keratitis in rabbits. ( Ishibashi, Y; Matsumoto, Y, 1984) |
| "A case of monilial granuloma of 12 years duration is being successfully treated with ketoconazole administered orally in doses of 200 mg per day." | 7.67 | [Monilial granuloma treated successfully with ketoconazole over a period of 30 months]. ( Deschamps, P; Leroy, D; Mahoudeau, J; Michel, M; Vion, M, 1984) |
| "A neonate who developed systemic candidiasis was successfully treated with oral ketoconazole (Nizoral; Janssen) and flucytosine (Alcobon; Roche)." | 7.67 | Oral ketoconazole and flucytosine for neonatal systemic candidiasis. ( Cotton, MF; Ransome, OJ, 1989) |
| "Although ketoconazole has been shown to be effective in treating esophageal candidiasis in other immunodeficiency states, similar studies have not been reported in patients with acquired immunodeficiency syndrome." | 7.67 | Ketoconazole-resistant Candida esophagitis in patients with acquired immunodeficiency syndrome. ( Dincsoy, HP; Raufman, JP; Rosenthal, LE; Tavitian, A; Webber, CA; Weber, J, 1986) |
| "The authors report the results of treatment with ketoconazole in 8 patients with chronic mucocutaneous candidiasis (CMC)." | 7.67 | Ketoconazole treatment of chronic mucocutaneous candidiasis. ( Montagnani, A; Negosanti, M; Patrizi, A, 1986) |
| "Thirty-two diabetic patients with vaginal candidiasis were treated orally with 400 mg ketoconazole once daily for five days." | 7.67 | Treatment with ketoconazole in diabetic patients with vaginal candidiasis. ( Balbi, C; Balbi, GC; D'Ajello, M, 1986) |
| "Topical ketoconazole (2% ointment three times per day for three weeks) markedly reduced the severity of keratitis produced with Candida albicans inoculation in the right eyes of 20 rabbits." | 7.67 | Topical ketoconazole for experimental Candida keratitis in rabbits. ( Ishibashi, Y; Kaufman, HE, 1986) |
| "The present study evaluated the activity of ketoconazole in neutropenic dogs with systemic candidiasis." | 7.67 | Treatment of systemic candidiasis in neutropenic dogs with ketoconazole. ( Epstein, RB; Gawith, KE; Keppen, M; Weber, MJ, 1985) |
| "Two cases of heroin abusers who developed disseminated candidiasis are reported." | 7.67 | Disseminated candidiasis with extensive folliculitis in abusers of brown Iranian heroin. ( Baudraz-Rosselet, F; Calandra, T; Francioli, P; Glauser, MP; Grigoriu, D; Ruffieux, C, 1985) |
| "An 8-year-old girl with chronic mucocutaneous candidiasis was treated with Ketoconazole 100 mg daily for 6 weeks." | 7.66 | Ketoconazole in a case of chronic mucocutaneous candidiasis. ( Laurberg, G; Thestrup-Pedersen, K; Zachariae, H, 1982) |
| "Five patients received ketoconazole treatment of chronic mucocutaneous candidiasis." | 7.66 | Ketoconazole treatment of chronic mucocutaneous candidiasis. ( Graybill, JR; Herndon, JH; Kniker, WT; Levine, HB, 1980) |
| "A father and son, both suffering from chronic mucocutaneous candidiasis, were successfully treated with oral ketoconazole, a water-soluble imidazole compound." | 7.66 | Familial chronic mucocutaneous candidiasis successfully treated with oral ketoconazole. ( Anderson, R; Morrison, JG, 1981) |
| "Our experience in the treatment of chronic mucocutaneous candidiasis with ketoconazole is reviewed." | 7.66 | Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole: experience with twenty-one patients. ( Horsburgh, CR; Kirkpatrick, CH, 1983) |
| "Forty-eight cases of deep mycoses were studied and treated with ketoconazole, each with in vitro evaluation of the minimum inhibitory concentrations (MIC) of the causative fungi, in vivo pharmacokinetic, clinical, and mycologic evaluations, several months to two years after the treatment was stopped." | 7.66 | Laboratory and clinical assessment of ketoconazole in deep-seated mycoses. ( Drouhet, E; Dupont, B, 1983) |
| "We report the clinical and laboratory findings in two children with chronic mucocutaneous candidiasis (CMC) treated successfully with intermittent long-term ketoconazole therapy." | 7.66 | Intermittent ketoconazole therapy of chronic mucocutaneous candidiasis in childhood. ( Fanconi, S; Issler, C; Joller, P; Schär, G; Seger, R, 1982) |
| "Three patients with esophageal candidiasis were treated with a new orally administered antifungal agent, ketoconazole." | 7.66 | Esophageal candidiasis: treatment with ketoconazole. ( Blackburn, WD; Gregory, DW; Madhavan, SV; Manske, CL; Stratton, CW, 1983) |
| "Treatment with fluconazole, 200 mg/day, was introduced." | 5.29 | [Clinical fluconazole and itraconazole resistance of oro-gastrointestinal candidiasis in a patient with AIDS]. ( Boyvat, A; Geilen, CC; Orfanos, CE; Seibold, M; Tebbe, B; Wölfer, LU, 1996) |
| " She was treated continuously for 6 years with ketoconazole at the same dosage of 200 mg/day." | 5.28 | Aneurysm associated with chronic mucocutaneous candidiasis during long-term therapy with ketoconazole. ( Dompmartin, A; Houtteville, JP; Leroy, D; Theron, J, 1989) |
| "Ketoconazole was prescribed because, unlike amphotericin B, the antibiotic usually used in such cases, it is not nephrotoxic, it can be taken orally and it has proved successful in other reported cases of osteomyelitis due to C." | 5.28 | Ketoconazole in the treatment of osteomyelitis due to Candida albicans. ( Bannatyne, RM; Clarke, HM, 1989) |
| "Candida sepsis has become an increasing problem in ICU patients with up to 50 per cent mortality rate." | 5.28 | The use of ketoconazole in prophylaxis of Candida sepsis. ( Lloyd, L; Rietschel, P; VanEgmond, E, 1989) |
| "Ketoconazole was used in 11 patients to treat 12 episodes of fungal urinary infections: 6 in the upper urinary tract and 6 presumed to be in the lower urinary tract." | 5.27 | Ketoconazole therapy for fungal urinary tract infections. ( Galgiani, JN; Graybill, JR; Jorgensen, JH; Strandberg, DA, 1983) |
| "Ketoconazole in this study was universally effective." | 5.27 | Ketoconazole treatment of Candida esophagitis--a prospective study of 12 cases. ( Arsura, EL; Fazio, RA; Wickremesinghe, PC, 1983) |
| "Ketoconazole is a synthetic imidazole derivative indicated in the treatment of superficial and deep mycoses (1)." | 5.27 | Persistent oesophageal candidiasis treated with ketoconazole. ( MacLeod, MD, 1983) |
| "Ketoconazole is a newly available oral antifungal agent with activity against candida species." | 5.27 | Ketoconazole treatment of nail infection in chronic mucocutaneous candidiasis. ( Hosking, CS; Roberton, DM, 1983) |
| "Fungal acalculous cholecystitis is a rarely recognized complication of disseminated candidal infections." | 5.26 | Apparent ketoconazole failure in candidal cholecystitis. ( Brooks, BJ; Marier, RL; Sanders, CV; Williams, WL, 1982) |
| "This randomized comparative study assessed the efficacy and safety of a 10-mg once-daily topical regimen of miconazole nitrate mucoadhesive buccal tablet (n = 178) versus a 400-mg once-daily systemic regimen of ketoconazole (n = 179) in HIV-positive patients with oropharyngeal candidiasis." | 5.11 | Comparative efficacy of topical therapy with a slow-release mucoadhesive buccal tablet containing miconazole nitrate versus systemic therapy with ketoconazole in HIV-positive patients with oropharyngeal candidiasis. ( Haxaire, M; Kamya, M; Katabira, E; Lwanga, I; Van Roey, J, 2004) |
| "To evaluate the effectiveness of the combination of ketoconazol 400 mg + clindamycin 100 mg for 6 days compared to ketoconazol 800 mg + clindamycin 100 mg in Candida vaginitis and bacterial vaginosis." | 5.11 | [Comparison of efficacy of combination of ketokonazol 400 mg + clindamycin 100 mg with ketokonazol 800 mg + clindamycin 100 mg in the treatment of vaginitis due to Candida and bacterial vaginosis]. ( Garibay, M; Godínez, V; Mirabent, F; Pérez Calderón, A, 2005) |
| "After the first episode of esophageal candidiasis, 122 consecutive AIDS patients were randomly assigned to two different regimens of continuous long-term antifungal prophylaxis (ketoconazole 200 mg or fluconazole 50 mg/day p." | 5.07 | Prevention of symptomatic recurrences of esophageal candidiasis in AIDS patients after the first episode: a prospective open study. ( Antinori, S; Ardizzone, S; Bianchi Porro, G; Cernuschi, M; Esposito, R; Lazzarin, A; Moroni, M; Parente, F, 1994) |
| "To determine the clinical and endoscopic response of candida esophagitis to antifungal therapy and to compare the two oral antifungal agents, fluconazole and ketoconazole." | 5.07 | Fluconazole compared with ketoconazole for the treatment of Candida esophagitis in AIDS. A randomized trial. ( Conteas, CN; Dretler, RH; Islam, MZ; Koster, FM; Laine, L; Sattler, F; Squires, K; Tuazon, C, 1992) |
| " In a neutropenic mouse model, itraconazole appeared to be as effective as amphotericin B against Candida albicans, and was more effective than amphotericin B in treating an Aspergillus infection in a patient with chronic granulomatous disease." | 5.07 | Itraconazole in neutropenic patients. ( van't Wout, JW, 1992) |
| "The recently developed antifungal agents itraconazole and fluconazole have been evaluated for primary and maintenance therapy for mycoses in patients with acquired immune deficiency syndrome (AIDS) in comparative and non-comparative trials." | 5.07 | Opportunistic fungal infections in patients with acquired immune deficiency syndrome. ( Viviani, MA, 1992) |
| "To determine the efficacy and toxicity of two systemically active antifungal agents in the treatment of buccal and oesophageal candidiasis 111 HIV-infected patients with microscopically-confirmed candidiasis were randomized to receive either 200 mg itraconazole once a day or 200 mg ketoconazole twice a day for 28 days in a double blind study." | 5.07 | Itraconazole versus ketaconazole in the treatment of oral and oesophageal candidosis in patients infected with HIV. ( Allan, M; Connolly, GM; Gazzard, BG; Midgley, J; Smith, DE, 1991) |
| "Long-term results of initial ketoconazole treatment were evaluated in 13 patients with chronic mucocutaneous candidiasis followed up for 3 years." | 5.06 | Ketoconazole treatment of 13 patients with chronic mucocutaneous candidiasis. A prospective 3-year trial. ( Mobacken, H; Moberg, S, 1986) |
| "We conducted a randomized prospective study to compare the efficacy of oral miconazole and ketoconazole in the treatment of candida esophagitis in acquired immune deficiency syndrome (AIDS) patients in Haiti." | 5.06 | Treatment of candida esophagitis in AIDS patients. ( DeHovitz, J; Deschamps, MM; Johnson, WD; Pape, JW; Thomas, F; Verdier, RI, 1988) |
| "The authors present the use of ketoconazole in 27 cases of paracoccidioidomycosis, eight of mycetoma, seven of chromomycosis, four of systemic candidiasis and one of lobomycosis." | 5.05 | Treatment of paracoccidioidomycosis, candidiasis, chromomycosis, lobomycosis, and mycetoma with ketoconazole. ( Cucé, LC; Sampaio, SA; Wroclawski, EL, 1980) |
| "Ketoconazole, a new oral antifungal agent, was evaluated in the treatment of four patients with severe chronic mucocutaneous candidiasis refractory to standard antifungal therapy." | 5.05 | Successful treatment of chronic mucocutaneous candidiasis with ketoconazole. ( Ament, ME; Byrne, W; Graybill, J; Rosenblatt, HM; Stiehm, ER, 1980) |
| "Twelve patients with chronic mucocutaneous candidiasis were assigned by random allocation to a 6-month course of treatment with ketoconazole or placebo in a double-blind trial." | 5.05 | Treatment of chronic mucocutaneous candidiasis with ketoconazole: a controlled clinical trial. ( Alling, DW; Kirkpatrick, CH; Petersen, EA, 1980) |
| "A multicenter double-blind study was conducted on the use of ketoconazole and griseofulvin for the treatment of dermatomycoses." | 5.05 | A multicenter double-blind evaluation of ketoconazole in the treatment of dermatomycoses. ( Daily, AD; Glogau, R; Jolly, HW; Krupp, I; Rex, IH; Stegman, SJ; Tromovitch, TA, 1983) |
| "A systematic review of randomized clinical trials published between 1966 and April 2000 was undertaken to determine the strength of evidence for the effectiveness of antifungal drugs (nystatin, clotrimazole, amphotericin B, fluconazole, ketoconazole, and itraconazole) to prevent and treat oral candidiasis in human immunodeficiency virus-positive patients." | 4.81 | A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients. ( Bonito, AJ; Patton, LL; Shugars, DA, 2001) |
| "Itraconazole and fluconazole are two relatively new anti-fungal agents which are being used successfully in the treatment of oropharyngeal candidiasis." | 4.78 | Itraconazole and fluconazole in oropharyngeal candidiasis. ( Arendorf, TM; van der Bijl, P, 1993) |
| " The case of a patient with environmental illness and systemic candidiasis for six weeks with ketoconazole, liver enzyme concentrations increased." | 4.78 | Ketoconazole hepatotoxicity in a patient treated for environmental illness and systemic candidiasis. ( Brusko, CS; Marten, JT, 1991) |
| "Esophageal candidiasis was diagnosed at endoscopy in two patients receiving omeprazole therapy." | 3.69 | Esophageal candidiasis following omeprazole therapy: a report of two cases. ( Chawla, LS; Jain, NP; Kumar, R; Sharma, M; Sood, A, 1995) |
| "In our study 77 AIDS patients suffering from oral and/or esophageal candidiasis were evaluated: 38 received fluconazole, 39 ketoconazole." | 3.68 | Fluconazole and ketoconazole in the treatment of oral and esophageal candidiasis in AIDS patients. ( Ancarani, F; Arzeni, D; Barchiesi, F; Branchesi, P; Crescenzi, G; Giacometti, A; Scalise, G, 1992) |
| " Itraconazole was superior to fluconazole in candidosis, cryptococcosis, sporotrichosis and aspergillosis, and to amphotericin B and to flucytosine in candidosis, cryptococcosis and aspergillosis." | 3.68 | In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents. ( Van Cutsem, J, 1992) |
| "The management of a preterm neonate with systemic candidiasis using oral itraconazole is described." | 3.68 | Itraconazole therapy for disseminated candidiasis in a very low birthweight neonate. ( Bhakoo, ON; Bhandari, V; Kumar, B; Nair, PM; Narang, A; Singh, M, 1992) |
| "The in vitro interaction of pentamidine with ketoconazole and with itraconazole was studied with 10 strains of Candida albicans isolated from acquired immunodeficiency syndrome patients and one azole-resistant strain." | 3.68 | Effects of pentamidine alone and in combination with ketoconazole or itraconazole on the growth of Candida albicans. ( St-Germain, G, 1990) |
| "The triazole Bay R 3783 was compared with fluconazole, itraconazole, ketoconazole, and amphotericin B in rodent models of superficial and systemic candidiasis, meningocerebral cryptococcosis, and pulmonary aspergillosis." | 3.68 | Evaluation of Bay R 3783 in rodent models of superficial and systemic candidiasis, meningeal cryptococcosis, and pulmonary aspergillosis. ( Hector, RF; Yee, E, 1990) |
| "We have treated 48 cases of onychomycosis (of which 37 were caused by dermatophytes, 10 by yeasts and one by Scopulariopsis brevicaulis) with 200 mg ketoconazole daily." | 3.67 | [Ketoconazole and onychomycosis]. ( Achten, G; André, J; Parent, D; Wiame, L, 1984) |
| "Oral ketoconazole (100 mg daily for 3 weeks) markedly reduced the severity of experimental Candida albicans keratitis in a group of 10 rabbits." | 3.67 | Oral ketoconazole therapy for experimental candida albicans keratitis in rabbits. ( Ishibashi, Y; Matsumoto, Y, 1984) |
| "Twenty six children with candidiasis, aged between 5 months and 14 years, were treated with different formulations and regimens of ketoconazole." | 3.67 | Pharmacokinetics of ketoconazole and treatment evaluation in candidal infections. ( Bardare, M; Pietrogrande, MC; Tortorano, AM; Viviani, MA, 1984) |
| "A case of monilial granuloma of 12 years duration is being successfully treated with ketoconazole administered orally in doses of 200 mg per day." | 3.67 | [Monilial granuloma treated successfully with ketoconazole over a period of 30 months]. ( Deschamps, P; Leroy, D; Mahoudeau, J; Michel, M; Vion, M, 1984) |
| "In an experimental model of persistent systemic candidiasis the effect of the thiazole compound Tiprotimod was examined." | 3.67 | Influence of the immunostimulating substance tiprotimod on Candida albicans infection in relation to activation of macrophages. ( Dickneite, G; Schorlemmer, HU; Sedlacek, HH, 1989) |
| "We compared the efficacies of the new triazole antifungal drugs fluconazole and itraconazole with that of amphotericin B in vitro and in an animal model of systemic candidiasis in normal and neutropenic mice." | 3.67 | Comparison of the efficacies of amphotericin B, fluconazole, and itraconazole against a systemic Candida albicans infection in normal and neutropenic mice. ( Mattie, H; van Furth, R; Van t Wout, JW, 1989) |
| "A neonate who developed systemic candidiasis was successfully treated with oral ketoconazole (Nizoral; Janssen) and flucytosine (Alcobon; Roche)." | 3.67 | Oral ketoconazole and flucytosine for neonatal systemic candidiasis. ( Cotton, MF; Ransome, OJ, 1989) |
| "Combination pairs of 5-fluorocytosine (5-FC) + itraconazole (Itra), 5-FC + fluconazole (Fluc), and amphotericin B (Amph B) + Itra were administered to mice with experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis with a variety of combination ratios." | 3.67 | Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice. ( Polak, A, 1987) |
| "Although ketoconazole has been shown to be effective in treating esophageal candidiasis in other immunodeficiency states, similar studies have not been reported in patients with acquired immunodeficiency syndrome." | 3.67 | Ketoconazole-resistant Candida esophagitis in patients with acquired immunodeficiency syndrome. ( Dincsoy, HP; Raufman, JP; Rosenthal, LE; Tavitian, A; Webber, CA; Weber, J, 1986) |
| "The authors report the results of treatment with ketoconazole in 8 patients with chronic mucocutaneous candidiasis (CMC)." | 3.67 | Ketoconazole treatment of chronic mucocutaneous candidiasis. ( Montagnani, A; Negosanti, M; Patrizi, A, 1986) |
| "Thirty-two diabetic patients with vaginal candidiasis were treated orally with 400 mg ketoconazole once daily for five days." | 3.67 | Treatment with ketoconazole in diabetic patients with vaginal candidiasis. ( Balbi, C; Balbi, GC; D'Ajello, M, 1986) |
| "Topical ketoconazole (2% ointment three times per day for three weeks) markedly reduced the severity of keratitis produced with Candida albicans inoculation in the right eyes of 20 rabbits." | 3.67 | Topical ketoconazole for experimental Candida keratitis in rabbits. ( Ishibashi, Y; Kaufman, HE, 1986) |
| "The present study evaluated the activity of ketoconazole in neutropenic dogs with systemic candidiasis." | 3.67 | Treatment of systemic candidiasis in neutropenic dogs with ketoconazole. ( Epstein, RB; Gawith, KE; Keppen, M; Weber, MJ, 1985) |
| "Two cases of heroin abusers who developed disseminated candidiasis are reported." | 3.67 | Disseminated candidiasis with extensive folliculitis in abusers of brown Iranian heroin. ( Baudraz-Rosselet, F; Calandra, T; Francioli, P; Glauser, MP; Grigoriu, D; Ruffieux, C, 1985) |
| "An 8-year-old girl with chronic mucocutaneous candidiasis was treated with Ketoconazole 100 mg daily for 6 weeks." | 3.66 | Ketoconazole in a case of chronic mucocutaneous candidiasis. ( Laurberg, G; Thestrup-Pedersen, K; Zachariae, H, 1982) |
| "Five patients received ketoconazole treatment of chronic mucocutaneous candidiasis." | 3.66 | Ketoconazole treatment of chronic mucocutaneous candidiasis. ( Graybill, JR; Herndon, JH; Kniker, WT; Levine, HB, 1980) |
| "A father and son, both suffering from chronic mucocutaneous candidiasis, were successfully treated with oral ketoconazole, a water-soluble imidazole compound." | 3.66 | Familial chronic mucocutaneous candidiasis successfully treated with oral ketoconazole. ( Anderson, R; Morrison, JG, 1981) |
| "I treated seven patients with keratomycosis (four with Candida infections and three with Aspergillus infections) with topical and subconjunctival miconazole." | 3.66 | Miconazole therapy for keratomycosis. ( Foster, CS, 1981) |
| "5 mg/kg, BID, administered orally for 18 days, followed by 8 biweekly oral doses of levamisole hydrochloride at the rate of 9 mg/kg, resulted in regression of clinical signs of candidiasis in an adult male Atlantic bottlenose dolphin (Tursiops truncatus)." | 3.66 | Candidiasis in captive cetaceans. ( Buck, JD; Dunn, JL; Spotte, S, 1982) |
| "Ketoconazole, an oral, broad-spectrum antifungal agent with relatively low toxicity, is the preferred drug for treatment of chronic mucocutaneous candidiasis and an alternative choice for treatment of thrush, vaginitis, histoplasmosis, and coccidioidomycosis." | 3.66 | Oral antifungal therapy. Current status of ketoconazole. ( Varkey, B, 1983) |
| "Ketoconazole is an effective treatment for chronic superficial candidiasis as well as chronic dermatophytosis." | 3.66 | Ketoconazole in the treatment of fungal infection. Clinical and laboratory studies. ( Hay, RJ, 1983) |
| "Clinical observations made on a group of six children and three adults indicate that ketoconazole is a safe and effective fungistatic agent that is useful for both initial and long-term maintenance therapy of mucocutaneous lesions due to infection by sensitive strains of Candida in patients with chronic mucocutaneous candidiasis." | 3.66 | Therapy of chronic mucocutaneous candidiasis. ( Rosenblatt, HM; Stiehm, ER, 1983) |
| "Our experience in the treatment of chronic mucocutaneous candidiasis with ketoconazole is reviewed." | 3.66 | Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole: experience with twenty-one patients. ( Horsburgh, CR; Kirkpatrick, CH, 1983) |
| "Forty-eight cases of deep mycoses were studied and treated with ketoconazole, each with in vitro evaluation of the minimum inhibitory concentrations (MIC) of the causative fungi, in vivo pharmacokinetic, clinical, and mycologic evaluations, several months to two years after the treatment was stopped." | 3.66 | Laboratory and clinical assessment of ketoconazole in deep-seated mycoses. ( Drouhet, E; Dupont, B, 1983) |
| "Combination pairs of the major systematic antimycotic drugs, amphotericin B (AmphB), 5-fluorocytosine (5-FC) and ketoconazole (Ktz) were administered to mice with experimental candidiasis, cryptococcosis and aspergillosis at a variety of combination ratios." | 3.66 | Combination therapy of experimental candidiasis, cryptococcosis and aspergillosis in mice. ( Polak, A; Scholer, HJ; Wall, M, 1982) |
| "We report the clinical and laboratory findings in two children with chronic mucocutaneous candidiasis (CMC) treated successfully with intermittent long-term ketoconazole therapy." | 3.66 | Intermittent ketoconazole therapy of chronic mucocutaneous candidiasis in childhood. ( Fanconi, S; Issler, C; Joller, P; Schär, G; Seger, R, 1982) |
| "Three patients with esophageal candidiasis were treated with a new orally administered antifungal agent, ketoconazole." | 3.66 | Esophageal candidiasis: treatment with ketoconazole. ( Blackburn, WD; Gregory, DW; Madhavan, SV; Manske, CL; Stratton, CW, 1983) |
| "Ketoconazole was used in the form of tablets and instillations." | 2.67 | [Imidazoles in the treatment of ocular mycoses]. ( Diadina, UV; Lapshina, NA; Maĭchuk, IuF, 1991) |
| "Ketoconazole was administered as a single daily oral dose of 200 mg to 12 patients with chronic mucocutaneous candidosis (CMC) of autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy (APECED)." | 2.66 | Ketoconazole is effective against the chronic mucocutaneous candidosis of autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy (APECED). ( Ahonen, P; Kahanpää, A; Myllärniemi, S; Perheentupa, J, 1986) |
| "Ketoconazole was better tolerated and more effective than nystatin in reducing colonization due to Candida species but was also associated with significantly increased rates of colonization with T." | 2.66 | Comparative trial of ketoconazole and nystatin for prevention of fungal infection in neutropenic patients treated in a protective environment. ( Klosterman, A; Meyers, JD; Shepp, DH; Siegel, MS, 1985) |
| "Ketoconazole or miconazole was randomly administered to 42 and 46 neutropenic patients respectively." | 2.65 | Oral prophylaxis with miconazole or ketoconazole of invasive fungal disease in neutropenic cancer patients. ( Cruciani, M; Klastersky, J; Meunier-Carpentier, F, 1983) |
| " This article reviews recent pertinent data with regard to dosing guidelines, efficacy, and toxicities of available systemic antifungal agents in the newborn." | 2.42 | Antifungal pharmacotherapy for neonatal candidiasis. ( Bliss, JM; Gigliotti, F; Wellington, M, 2003) |
| "Ketoconazole tablets were used with good success in previous years of the AIDS epidemics." | 2.39 | [Therapy of candidiasis and cryptococcosis in AIDS]. ( Just-Nübling, G, 1994) |
| "For treatment, amphotericin B remains the standard antifungal agent, and the association of amphotericin B with flucytosine the recommended association." | 2.38 | [Systemic candidiasis]. ( Lelarge, P; Mariot, J, 1992) |
| "Invasive fungal infections are common in immunocompromised patients." | 2.38 | [Systemic mycotic infections]. ( Meunier, F, 1990) |
| "Systemic candidiasis is a disease of increasing incidence and proportions, which appears to be associated with the advances in modern medicine." | 2.38 | Systemic candidiasis. ( Ray, TL, 1989) |
| "The deep mycoses are increasing in importance both as opportunistic infections and from exposure in geographically defined areas." | 2.37 | Cutaneous and mucosal manifestations of the deep mycotic infections. ( Meyer, RD, 1986) |
| " After 7 days of exposure to 200 mg of ketoconazole once daily, the AUC0-t and Cmax of the parent drug were not affected significantly." | 1.40 | Effects of rifampin and ketoconazole on pharmacokinetics of morinidazole in healthy chinese subjects. ( Chen, X; Gao, R; Pang, X; Zhang, Y; Zhong, D; Zhong, K, 2014) |
| " However, when allicin was used in combination with fluconazole or ketoconazole, the MICs were decreased in some isolates." | 1.36 | In vitro investigation of antifungal activity of allicin alone and in combination with azoles against Candida species. ( Aala, F; Alizadeh, F; Chong, PP; Khodavandi, A; Sekawi, Z, 2010) |
| "albicans can alter the ability of murine B16 melanoma (B16M) cells to colonize the liver." | 1.36 | Candida albicans enhances experimental hepatic melanoma metastasis. ( de Cerio, AA; Gallot, N; Hernando, FL; Martínez-de-Tejada, G; Mendoza, L; Rodríguez-Cuesta, J; Vidal-Vanaclocha, F, 2010) |
| "Invasive candidiasis is associated with high morbidity and mortality." | 1.35 | Direct antifungal susceptibility testing of positive Candida blood cultures by sensititre YeastOne. ( Avolio, M; Bruschetta, G; Camporese, A; De Rosa, R; Grosso, S, 2009) |
| "Ketoconazole may cause severe anaphylactic shock even when taken orally." | 1.33 | Refractory anaphylactic shock associated with ketoconazole treatment. ( Chen, JH; Lee, CH; Lin, LJ; Liu, PY, 2005) |
| " The strains susceptibility to K (RO4 1400 Janssen) was estimated with the own system based on the dose-response curves; the minimal inhibitory concentration (MIC) values were canculated." | 1.31 | [The sensitivity to ketoconazole of Candida strains isolated from the digestive tract ontocenoses in children]. ( Horwatt-Bozyczko, E; Kurnatowska, A; Kurnatowski, M; Wasowska-Królikowska, K, 2001) |
| "Fluconazole is an effective and less toxic alternative to prolonged courses of amphotericin B in the treatment of neonatal renal candidiasis." | 1.29 | Neonatal renal candidiasis. ( Bailey, CJ; Cartledge, JM; Morris, SA, 1994) |
| "Amphotericin B is the treatment of choice for acute and chronic hematogenously disseminated candidiasis." | 1.29 | Severe candidal infections in neutropenic patients. ( Edwards, JE; Filler, SG; Swerdloff, JN, 1993) |
| "A report on a patient with multiple myeloma, undergoing bone marrow transplant, who developed systemic fungal infection due to Candida krusei after bone marrow transplantation." | 1.29 | Changing pattern of Candida species in a bone marrow transplant patient. ( Banerjee, U; Fotedar, R, 1996) |
| "Treatment with fluconazole, 200 mg/day, was introduced." | 1.29 | [Clinical fluconazole and itraconazole resistance of oro-gastrointestinal candidiasis in a patient with AIDS]. ( Boyvat, A; Geilen, CC; Orfanos, CE; Seibold, M; Tebbe, B; Wölfer, LU, 1996) |
| "A concomitant pyogenic brain abscess responded to burrhole aspiration and antibiotics." | 1.28 | Ventriculitis and hydrocephalus caused by Candida albicans successfully treated by antimycotic therapy and cerebrospinal fluid shunting. ( al-Abedeen Jamjoom, Z; al-Hedaithy, S; Jamali, A; Jamjoom, A; Malabarey, T, 1992) |
| "Ketoconazole was effective in controlling symptoms of candidiasis in most patients." | 1.28 | Chronic mucocutaneous candidiasis in childhood and complications of non-Candida infection: a report of the Pediatric Immunodeficiency Collaborative Study Group. ( Herrod, HG, 1990) |
| " She was treated continuously for 6 years with ketoconazole at the same dosage of 200 mg/day." | 1.28 | Aneurysm associated with chronic mucocutaneous candidiasis during long-term therapy with ketoconazole. ( Dompmartin, A; Houtteville, JP; Leroy, D; Theron, J, 1989) |
| "Ketoconazole was prescribed because, unlike amphotericin B, the antibiotic usually used in such cases, it is not nephrotoxic, it can be taken orally and it has proved successful in other reported cases of osteomyelitis due to C." | 1.28 | Ketoconazole in the treatment of osteomyelitis due to Candida albicans. ( Bannatyne, RM; Clarke, HM, 1989) |
| "Candida sepsis has become an increasing problem in ICU patients with up to 50 per cent mortality rate." | 1.28 | The use of ketoconazole in prophylaxis of Candida sepsis. ( Lloyd, L; Rietschel, P; VanEgmond, E, 1989) |
| "Disseminated candidiasis is likely to become an increasing problem in cancer patients." | 1.27 | Candidiasis in cancer patients. ( Bodey, GP, 1984) |
| "Candidiasis was characterized by purulent nasal discharge, inflammation of the lips at the mucocutaneous junction, periocular alopecia, vaginitis, and dermatitis." | 1.27 | Candidiasis in captive pinnipeds. ( Buck, JD; Dunn, JL; Spotte, S, 1984) |
| "Invasive fungal infections are becoming increasingly frequent among immunocompromised patients and especially among cancer patients." | 1.27 | Treatment of mycoses in cancer patients. ( Meunier-Carpentier, F, 1983) |
| "Ketoconazole was used in 11 patients to treat 12 episodes of fungal urinary infections: 6 in the upper urinary tract and 6 presumed to be in the lower urinary tract." | 1.27 | Ketoconazole therapy for fungal urinary tract infections. ( Galgiani, JN; Graybill, JR; Jorgensen, JH; Strandberg, DA, 1983) |
| "Ketoconazole in this study was universally effective." | 1.27 | Ketoconazole treatment of Candida esophagitis--a prospective study of 12 cases. ( Arsura, EL; Fazio, RA; Wickremesinghe, PC, 1983) |
| "Ketoconazole is a synthetic imidazole derivative indicated in the treatment of superficial and deep mycoses (1)." | 1.27 | Persistent oesophageal candidiasis treated with ketoconazole. ( MacLeod, MD, 1983) |
| "Ketoconazole is a newly available oral antifungal agent with activity against candida species." | 1.27 | Ketoconazole treatment of nail infection in chronic mucocutaneous candidiasis. ( Hosking, CS; Roberton, DM, 1983) |
| "The spondylitis was probably superinfected with Staphylococcus aureus." | 1.27 | Hematogenous Candida spondylitis. A case report. ( Pohjola-Sintonen, S; Ruutu, P; Tallroth, K, 1984) |
| "A patient with diabetes mellitus and acute renal failure requiring hemodialysis developed Candida sepsis which was effectively treated with the oral antifungal drug, ketoconazole." | 1.27 | Ketoconazole treatment of fungal infection in acute renal failure. ( Morrissey, RL; Nakasato, S; Shah, GM; Winer, RL, 1983) |
| "BAY N 7133 was also effective for mouse candidosis by parenteral administration and was effective for guinea pig trichophytosis on topical application." | 1.27 | Antimycotic activity of BAY N 7133 in animal experiments. ( Plempel, M, 1984) |
| "Ketoconazole was highly active in these experimental models." | 1.27 | [Anti-Candida activity of azoles]. ( Janssen, PA; Van Cutsem, J; Van Gerven, F, 1987) |
| "Oral treatment with fluconazole resulted in much higher serum and extravascular concentrations of this antifungal agent than did comparable doses of ketoconazole." | 1.27 | Activities of fluconazole (UK 49,858) and ketoconazole against ketoconazole-susceptible and -resistant Candida albicans. ( Beggs, WH; Bennett, RL; Hughes, CE; Tuna, IC, 1988) |
| " In a 10-day dosage regimen, UK-49,858 was far more active than ketoconazole against systemic infections with C." | 1.27 | Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice. ( Andrews, RJ; Brammer, KW; Marriott, MS; Richardson, K; Troke, PF, 1985) |
| "Chronic mucocutaneous candidiasis is a chronic infection of mucoses, nails and skin due to Candida sp." | 1.27 | [Chronic mucocutaneous candidiasis]. ( de Moragas, JM; García, MP; Pérez, M; Puig, L, 1988) |
| "Emphysematous cystitis is characterized by gas collection within the bladder wall and lumen." | 1.27 | Emphysematous prostatitis and cystitis secondary to Candida albicans. ( Bartkowski, DP; Lanesky, JR, 1988) |
| "Candidiasis was established by intravenously administering Candida albicans or Candida tropicalis (1-2 x 10(5) colony-forming units) and resulted in hepatic and splenic lesions that mimicked those associated with hepatosplenic candidiasis in humans." | 1.27 | Evaluation of single-drug and combination antifungal therapy in an experimental model of candidiasis in rabbits with prolonged neutropenia. ( Bacher, J; O'Leary, T; Pizzo, PA; Thaler, M, 1988) |
| "Hepatic candidiasis has been increasingly recognized as a variant of disseminated candidiasis in immunocompromised patients." | 1.27 | Hepatic candidiasis: an increasing problem in immunocompromised patients. ( Feld, R; Haron, E; Hasselback, R; Matlow, A; Patterson, B; Tuffnell, P, 1987) |
| "Ketoconazole penetration was average in the aqueous humour, significant in tears and poor in the vitreous." | 1.27 | Experimental study of the intra-ocular penetration of ketoconazole in rabbits. ( Arne, JL; Bec, P; Bessieres, MH; Linas, MD; Malecaze, F; Mathis, A; Recco, P, 1987) |
| "Disseminated histoplasmosis is a major opportunistic infection in patients with AIDS from endemic areas." | 1.27 | Histoplasmosis in the acquired immune deficiency syndrome. ( Slama, TG; Wheat, LJ; Zeckel, ML, 1985) |
| "One of them now has an early form of AIDS, while the other died of AIDS in its full form and her child, born in 1983, has fairly far progressed early symptoms of AIDS." | 1.27 | [Heterosexual transmission of the acquired immunodeficiency syndrome (AIDS)]. ( Bircher, A; Furger, F; Lang, W; Lüthy, R; Maurer, R; Siegenthaler, W; Vogt, M, 1985) |
| "Ketoconazole has been shown to be effective in the treatment of mucocutaneous candidiasis with a reported 97% positive response rate." | 1.27 | Ketoconazole and the antifungals. ( Parkin, JL, 1985) |
| "Miconazole also has been used as a systemic and local irrigant in the treatment of bladder and renal candidiasis." | 1.27 | Do the imidazoles have a role in the management of genitourinary fungal infections? ( Goldberg, PE; Kozinn, PJ; Wise, GJ, 1985) |
| " Pharmacokinetic studies indicated lower peak vibunazole and 9139 serum concentrations, and reduced area-under-curve (AUC), after 26 days of treatment, as against single dose administration." | 1.27 | New azole compounds: vibunazole (Bay n7133) and Bay L9139, compared with ketoconazole in the therapy of systemic candidosis and in pharmacokinetic studies, in mice. ( Lefler, E; Stevens, DA, 1985) |
| "Amphotericin B at lower maintenance dose, together with 5 flucytosine (5FC), are the preferred drugs for treatment of systemic candidiasis at present." | 1.27 | Systemic candidiasis in premature infants experience with drug treatment. ( Ho, NK, 1985) |
| "Fungal acalculous cholecystitis is a rarely recognized complication of disseminated candidal infections." | 1.26 | Apparent ketoconazole failure in candidal cholecystitis. ( Brooks, BJ; Marier, RL; Sanders, CV; Williams, WL, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 215 (61.08) | 18.7374 |
| 1990's | 86 (24.43) | 18.2507 |
| 2000's | 32 (9.09) | 29.6817 |
| 2010's | 16 (4.55) | 24.3611 |
| 2020's | 3 (0.85) | 2.80 |
| Authors | Studies |
|---|---|
| Heeres, J | 1 |
| Backx, LJ | 1 |
| Mostmans, JH | 1 |
| Van Cutsem, J | 7 |
| Mullen, GB | 1 |
| DeCory, TR | 1 |
| Mitchell, JT | 1 |
| Allen, SD | 1 |
| Kinsolving, CR | 1 |
| Georgiev, VS | 1 |
| Ogata, M | 1 |
| Matsumoto, H | 1 |
| Takahashi, K | 1 |
| Shimizu, S | 1 |
| Kida, S | 1 |
| Murabayashi, A | 1 |
| Shiro, M | 1 |
| Tawara, K | 1 |
| Artico, M | 2 |
| Di Santo, R | 1 |
| Costi, R | 1 |
| Massa, S | 1 |
| Retico, A | 1 |
| Apuzzo, G | 1 |
| Simonetti, G | 1 |
| Strippoli, V | 1 |
| Bartroli, J | 1 |
| Turmo, E | 1 |
| Algueró, M | 1 |
| Boncompte, E | 1 |
| Vericat, ML | 1 |
| García-Rafanell, J | 1 |
| Forn, J | 1 |
| Vandeputte, P | 2 |
| Tronchin, G | 2 |
| Bergès, T | 2 |
| Hennequin, C | 1 |
| Chabasse, D | 3 |
| Bouchara, JP | 3 |
| Yao, B | 1 |
| Ji, H | 1 |
| Cao, Y | 1 |
| Zhou, Y | 1 |
| Zhu, J | 1 |
| Lü, J | 1 |
| Li, Y | 2 |
| Chen, J | 1 |
| Zheng, C | 1 |
| Jiang, Y | 1 |
| Liang, R | 1 |
| Tang, H | 1 |
| Larcher, G | 1 |
| Ernoult, E | 1 |
| Lamping, E | 1 |
| Ranchod, A | 1 |
| Nakamura, K | 1 |
| Tyndall, JD | 1 |
| Niimi, K | 1 |
| Holmes, AR | 1 |
| Niimi, M | 1 |
| Cannon, RD | 1 |
| Aher, NG | 1 |
| Pore, VS | 1 |
| Mishra, NN | 1 |
| Kumar, A | 1 |
| Shukla, PK | 1 |
| Sharma, A | 1 |
| Bhat, MK | 1 |
| Garibotto, FM | 1 |
| Garro, AD | 1 |
| Masman, MF | 1 |
| Rodríguez, AM | 1 |
| Luiten, PG | 1 |
| Raimondi, M | 1 |
| Zacchino, SA | 1 |
| Somlai, C | 1 |
| Penke, B | 1 |
| Enriz, RD | 1 |
| Jiang, X | 1 |
| Liu, W | 1 |
| Zhang, W | 1 |
| Jiang, F | 1 |
| Gao, Z | 1 |
| Zhuang, H | 1 |
| Fu, L | 1 |
| Nayak, D | 1 |
| Tawale, RM | 1 |
| Aranjani, JM | 1 |
| Tippavajhala, VK | 1 |
| Darma, S | 1 |
| Ambara, A | 1 |
| Aman, AT | 1 |
| Annisa, L | 1 |
| Nuryastuti, T | 1 |
| Wibawa, T | 1 |
| Xu, Y | 1 |
| Lu, H | 1 |
| Zhu, S | 1 |
| Li, WQ | 1 |
| Jiang, YY | 1 |
| Berman, J | 1 |
| Yang, F | 1 |
| Jamil, B | 1 |
| Mukhtar Bokhari, MT | 1 |
| Saeed, A | 1 |
| Mukhtar Bokhari, MZ | 1 |
| Hussain, Z | 1 |
| Khalid, T | 1 |
| Bokhari, H | 1 |
| Imran, M | 1 |
| Abbasi, SA | 1 |
| Jiang, L | 1 |
| Pan, H | 1 |
| Guinea, J | 1 |
| Zaragoza, Ó | 1 |
| Escribano, P | 1 |
| Martín-Mazuelos, E | 1 |
| Pemán, J | 1 |
| Sánchez-Reus, F | 1 |
| Cuenca-Estrella, M | 1 |
| Block, SL | 1 |
| Pang, X | 1 |
| Zhang, Y | 1 |
| Gao, R | 1 |
| Zhong, K | 1 |
| Zhong, D | 1 |
| Chen, X | 1 |
| Ellepola, AN | 1 |
| Joseph, BK | 1 |
| Samaranayake, LP | 2 |
| Bandara, HM | 1 |
| Khan, ZU | 1 |
| Mahboubi, M | 1 |
| Kazempour, N | 1 |
| Nishikawa, JL | 1 |
| Boeszoermenyi, A | 1 |
| Vale-Silva, LA | 1 |
| Torelli, R | 1 |
| Posteraro, B | 1 |
| Sohn, YJ | 1 |
| Ji, F | 1 |
| Gelev, V | 1 |
| Sanglard, D | 1 |
| Sanguinetti, M | 1 |
| Sadreyev, RI | 1 |
| Mukherjee, G | 1 |
| Bhyravabhotla, J | 1 |
| Buhrlage, SJ | 1 |
| Gray, NS | 1 |
| Wagner, G | 1 |
| Näär, AM | 1 |
| Arthanari, H | 1 |
| Nawrot, U | 1 |
| Nowicka, J | 1 |
| Wlodarczyk, K | 1 |
| Avolio, M | 1 |
| Grosso, S | 1 |
| Bruschetta, G | 1 |
| De Rosa, R | 1 |
| Camporese, A | 1 |
| Khodavandi, A | 1 |
| Alizadeh, F | 1 |
| Aala, F | 1 |
| Sekawi, Z | 1 |
| Chong, PP | 2 |
| Rodríguez-Cuesta, J | 1 |
| Hernando, FL | 1 |
| Mendoza, L | 1 |
| Gallot, N | 1 |
| de Cerio, AA | 1 |
| Martínez-de-Tejada, G | 1 |
| Vidal-Vanaclocha, F | 1 |
| Samaranayake, YH | 1 |
| Yau, JY | 1 |
| Thein, ZM | 1 |
| Jayatilake, JA | 1 |
| Yeung, KW | 1 |
| Hoehamer, CF | 1 |
| Cummings, ED | 1 |
| Hilliard, GM | 1 |
| Rogers, PD | 1 |
| Blanche, S | 1 |
| Dupont, B | 3 |
| Chang, W | 1 |
| Zhang, L | 1 |
| Cheng, A | 1 |
| Liu, Y | 1 |
| Lou, H | 1 |
| Ohwada, J | 1 |
| Murasaki, C | 1 |
| Yamazaki, T | 1 |
| Ichihara, S | 1 |
| Umeda, I | 1 |
| Shimma, N | 1 |
| Ozkutuk, A | 1 |
| Ergon, C | 1 |
| Yulug, N | 1 |
| Hernandez-Divers, SJ | 1 |
| Garg, P | 1 |
| Mahesh, S | 1 |
| Bansal, AK | 1 |
| Gopinathan, U | 1 |
| Rao, GN | 1 |
| Bliss, JM | 1 |
| Wellington, M | 1 |
| Gigliotti, F | 1 |
| Van Roey, J | 1 |
| Haxaire, M | 1 |
| Kamya, M | 1 |
| Lwanga, I | 1 |
| Katabira, E | 1 |
| Silva, V | 2 |
| Alvarado, D | 2 |
| Diaz, MC | 2 |
| Liu, PY | 1 |
| Lee, CH | 1 |
| Lin, LJ | 1 |
| Chen, JH | 1 |
| Looi, CY | 1 |
| D' Silva, EC | 1 |
| Seow, HF | 1 |
| Rosli, R | 1 |
| Ng, KP | 1 |
| Godínez, V | 1 |
| Garibay, M | 1 |
| Mirabent, F | 1 |
| Pérez Calderón, A | 1 |
| Schiaffella, F | 1 |
| Macchiarulo, A | 1 |
| Milanese, L | 1 |
| Vecchiarelli, A | 1 |
| Fringuelli, R | 1 |
| Horwatt-Bozyczko, E | 1 |
| Kurnatowski, M | 1 |
| Wasowska-Królikowska, K | 1 |
| Kurnatowska, A | 1 |
| Pagano, R | 1 |
| Figueiredo, VT | 1 |
| de Assis Santos, D | 1 |
| Resende, MA | 1 |
| Hamdan, JS | 1 |
| Kanavi, MR | 1 |
| Foroutan, AR | 1 |
| Kamel, MR | 1 |
| Afsar, N | 1 |
| Javadi, MA | 1 |
| Lovacheva, OV | 1 |
| Kornienko, II | 1 |
| Kul'ko, AB | 1 |
| Slogotskaia, LV | 1 |
| Litvinov, VI | 1 |
| McCaw, D | 1 |
| Franklin, R | 1 |
| Fales, W | 1 |
| Stockham, S | 1 |
| Lattimer, J | 1 |
| Sheklakov, ND | 1 |
| Rukavishnikova, VM | 1 |
| Parent, D | 1 |
| Achten, G | 1 |
| André, J | 1 |
| Wiame, L | 1 |
| Bodey, GP | 3 |
| Maksymiuk, AW | 1 |
| Thongprasert, S | 1 |
| Hopfer, R | 1 |
| Luna, M | 1 |
| Fainstein, V | 1 |
| Quintiliani, R | 2 |
| Owens, NJ | 1 |
| Quercia, RA | 1 |
| Klimek, JJ | 1 |
| Nightingale, CH | 1 |
| Ishibashi, Y | 3 |
| Matsumoto, Y | 2 |
| Bardare, M | 1 |
| Tortorano, AM | 1 |
| Pietrogrande, MC | 1 |
| Viviani, MA | 3 |
| Corbeel, L | 1 |
| Ceuppens, JL | 1 |
| Van den Berghe, G | 1 |
| Claeys, H | 1 |
| Casteels-Van Daele, M | 1 |
| Dunn, JL | 2 |
| Buck, JD | 3 |
| Spotte, S | 2 |
| Lauver, MA | 1 |
| Barker, P | 1 |
| Auger, P | 1 |
| Péloquin, S | 1 |
| Joly, J | 1 |
| Montplaisir, S | 1 |
| Marquis, G | 1 |
| Badillet, G | 2 |
| Puissant, A | 1 |
| Colliard, H | 1 |
| Horseburgh, CR | 1 |
| Kirkpatrick, CH | 3 |
| Teutsch, CB | 1 |
| Ferguson, RM | 1 |
| Sutherland, DE | 1 |
| Simmons, RL | 2 |
| Najarian, JS | 1 |
| Zachariae, H | 1 |
| Laurberg, G | 1 |
| Thestrup-Pedersen, K | 1 |
| Coovadia, HM | 1 |
| Hamed, Z | 1 |
| Bayles, MA | 1 |
| Kiepiela, P | 1 |
| Gschnait, F | 1 |
| Odds, FC | 4 |
| Milne, LJ | 1 |
| Gentles, JC | 1 |
| Ball, EH | 1 |
| Fibbe, WE | 3 |
| Van Der Meer, JW | 3 |
| Thompson, J | 1 |
| Mouton, RP | 1 |
| Cucé, LC | 1 |
| Wroclawski, EL | 1 |
| Sampaio, SA | 1 |
| Rosenblatt, HM | 2 |
| Byrne, W | 1 |
| Ament, ME | 1 |
| Graybill, J | 1 |
| Stiehm, ER | 3 |
| Graybill, JR | 4 |
| Herndon, JH | 1 |
| Kniker, WT | 1 |
| Levine, HB | 1 |
| Petersen, EA | 1 |
| Alling, DW | 1 |
| Samelson, LE | 1 |
| Lerner, SA | 1 |
| Resnekov, L | 1 |
| Anagnostopoulos, C | 1 |
| Drutz, DJ | 1 |
| Murphy, AL | 1 |
| Morrison, JG | 1 |
| Anderson, R | 1 |
| Grimmer, H | 1 |
| Kennedy, CT | 2 |
| Valdimarsson, H | 1 |
| Hay, RJ | 4 |
| Foster, CS | 1 |
| Jones, DB | 2 |
| Zazgornik, J | 1 |
| Kopsa, H | 1 |
| Schmidt, P | 1 |
| Marosi, L | 1 |
| Balcke, P | 1 |
| Green, MT | 1 |
| Osato, MS | 1 |
| Broberg, PH | 1 |
| Gentry, LO | 1 |
| Chretien, JH | 1 |
| Garagusi, VF | 1 |
| Clayton, YM | 1 |
| Tkach, JR | 1 |
| Rinaldi, MG | 2 |
| Young, LS | 1 |
| Jones, HE | 1 |
| Appleboom, TM | 1 |
| Flowers, FP | 1 |
| Brooks, BJ | 1 |
| Williams, WL | 1 |
| Sanders, CV | 1 |
| Marier, RL | 1 |
| Rutgeerts, LJ | 1 |
| Symoens, J | 1 |
| Egere, JU | 1 |
| Gugnani, HC | 1 |
| Nzelibe, FK | 1 |
| Bossart, GD | 1 |
| Bossart, C | 1 |
| Varkey, B | 1 |
| Horsburgh, CR | 1 |
| Drouhet, E | 3 |
| Meunier-Carpentier, F | 4 |
| Hensey, OJ | 1 |
| Cooke, RW | 1 |
| Rand, R | 1 |
| Sober, AJ | 1 |
| Olmstead, PM | 1 |
| Polak, A | 3 |
| Scholer, HJ | 2 |
| Wall, M | 1 |
| Waugh, MA | 1 |
| Fanconi, S | 1 |
| Seger, R | 1 |
| Joller, P | 1 |
| Issler, C | 1 |
| Schär, G | 1 |
| Galgiani, JN | 2 |
| Jorgensen, JH | 1 |
| Strandberg, DA | 1 |
| Williamson, MM | 1 |
| Gordon, RD | 1 |
| Jolly, HW | 1 |
| Daily, AD | 1 |
| Rex, IH | 1 |
| Krupp, I | 1 |
| Tromovitch, TA | 1 |
| Stegman, SJ | 1 |
| Glogau, R | 1 |
| Hogg, RJ | 1 |
| Arant, BS | 1 |
| Houser, MT | 1 |
| Hector, RF | 2 |
| Domer, JE | 1 |
| Rempen, A | 1 |
| Tudehope, DI | 1 |
| Rigby, B | 1 |
| Cuena Boy, R | 1 |
| Azanza Perea, JR | 1 |
| Honorato Pérez, JM | 1 |
| Fazio, RA | 1 |
| Wickremesinghe, PC | 1 |
| Arsura, EL | 1 |
| Stamm, AM | 1 |
| Dismukes, WE | 1 |
| Cruciani, M | 1 |
| Klastersky, J | 1 |
| Palestine, RF | 1 |
| Su, WP | 1 |
| Liesegang, TJ | 1 |
| Gregory, DW | 1 |
| Blackburn, WD | 1 |
| Madhavan, SV | 1 |
| Manske, CL | 1 |
| Stratton, CW | 1 |
| Saule, H | 1 |
| Spors, S | 1 |
| Möller, A | 1 |
| MacLeod, MD | 1 |
| Roberton, DM | 1 |
| Hosking, CS | 1 |
| Collins, JR | 1 |
| Van Sickels, JE | 1 |
| Kozinn, PJ | 2 |
| Taschdjian, C | 1 |
| Wise, GJ | 2 |
| Valentová, M | 1 |
| Klobusický, M | 1 |
| Valent, M | 1 |
| Svedhem, A | 1 |
| Pohjola-Sintonen, S | 1 |
| Ruutu, P | 1 |
| Tallroth, K | 1 |
| O'Day, DM | 6 |
| Ray, WA | 3 |
| Robinson, R | 2 |
| Head, WS | 5 |
| Bennett, JE | 1 |
| Duquesnoy, B | 2 |
| Fournier, E | 1 |
| Berniere, L | 1 |
| Delcambre, B | 2 |
| Plempel, M | 2 |
| Feuilhade de Chauvin, M | 1 |
| Touraine, R | 1 |
| Nakasato, S | 1 |
| Shah, GM | 1 |
| Morrissey, RL | 1 |
| Winer, RL | 1 |
| Deutsch, PH | 1 |
| Zouali, M | 1 |
| Eyquem, A | 1 |
| Robinson, RD | 3 |
| Murphy, JF | 1 |
| Jones, M | 1 |
| Thompson, EN | 1 |
| García-Pérez, A | 1 |
| Gómez de la Concha, E | 1 |
| Guerra Rodríguez, P | 1 |
| Leroy, D | 2 |
| Michel, M | 1 |
| Vion, M | 1 |
| Mahoudeau, J | 1 |
| Deschamps, P | 1 |
| Just-Nübling, G | 1 |
| Denning, DW | 2 |
| Kalya, AV | 1 |
| Ahearn, DG | 1 |
| Force, RW | 1 |
| Nahata, MC | 1 |
| Robitaille, P | 1 |
| Mérouani, A | 1 |
| Clermónt, MJ | 1 |
| Hébert, E | 1 |
| Sood, A | 1 |
| Sharma, M | 1 |
| Jain, NP | 1 |
| Chawla, LS | 1 |
| Kumar, R | 1 |
| Dubé, MP | 1 |
| Heseltine, PN | 1 |
| Evans, S | 1 |
| Zawacki, B | 1 |
| Michel, C | 1 |
| Courdavault, L | 1 |
| al Khayat, R | 1 |
| Viron, B | 1 |
| Roux, P | 1 |
| Mignon, F | 1 |
| Symonds, JM | 1 |
| O'Dell, CA | 1 |
| Parente, F | 1 |
| Ardizzone, S | 1 |
| Cernuschi, M | 1 |
| Antinori, S | 1 |
| Esposito, R | 1 |
| Moroni, M | 1 |
| Lazzarin, A | 1 |
| Bianchi Porro, G | 1 |
| Morris, SA | 1 |
| Bailey, CJ | 1 |
| Cartledge, JM | 1 |
| Liao, WQ | 1 |
| Li, ZG | 1 |
| Guo, M | 1 |
| Zhang, JZ | 1 |
| van der Bijl, P | 1 |
| Arendorf, TM | 1 |
| Swerdloff, JN | 1 |
| Filler, SG | 1 |
| Edwards, JE | 1 |
| Savino, JA | 1 |
| Agarwal, N | 1 |
| Wry, P | 1 |
| Policastro, A | 1 |
| Cerabona, T | 1 |
| Austria, L | 1 |
| van den Anker, JN | 2 |
| van Lingen, RA | 1 |
| Koster, M | 1 |
| Heykants, J | 1 |
| Sauer, PJ | 1 |
| Neely, D | 1 |
| Mazor, M | 1 |
| Chaim, W | 1 |
| Shinwell, ES | 1 |
| Glezerman, M | 1 |
| Berman, DS | 1 |
| Wenglin, BD | 1 |
| Legg, JJ | 1 |
| Brossier, KA | 1 |
| Goldschmidt, RH | 1 |
| Thio, CL | 1 |
| Rutledge, TM | 1 |
| Roca, B | 1 |
| Arenas, M | 1 |
| Johnson, EM | 2 |
| Warnock, DW | 2 |
| Fotedar, R | 1 |
| Banerjee, U | 1 |
| Ali, A | 1 |
| Rünzi, M | 1 |
| Rosien, U | 1 |
| Goebell, H | 1 |
| Layer, P | 1 |
| Tebbe, B | 1 |
| Boyvat, A | 1 |
| Geilen, CC | 1 |
| Wölfer, LU | 1 |
| Seibold, M | 2 |
| Orfanos, CE | 1 |
| Krajewska-Kułak, E | 1 |
| Niczyporuk, W | 1 |
| Taylor, CB | 1 |
| Finlay, R | 1 |
| Richardson, C | 1 |
| Bunting, P | 1 |
| Welch, J | 1 |
| McDonald, JA | 1 |
| Saulsbury, FT | 1 |
| Baily, GG | 1 |
| Hood, SV | 1 |
| Batura-Gabryel, H | 1 |
| Wieczorek, U | 1 |
| Mlynarczyk, W | 1 |
| Simonian, PT | 1 |
| Brause, BD | 1 |
| Wickiewicz, TL | 1 |
| Burgaleta, C | 1 |
| Fortun Abete, J | 1 |
| Berenguer Berenguer, J | 1 |
| Laing, RB | 1 |
| Brettle, RP | 1 |
| Leen, CL | 1 |
| Araj, GF | 1 |
| Daher, NK | 1 |
| Tabbarah, ZA | 1 |
| Berrouane, YF | 1 |
| Herwaldt, LA | 1 |
| Pfaller, MA | 1 |
| Defontaine, A | 1 |
| Declerk, P | 1 |
| Planchenault, C | 1 |
| Hallet, JN | 1 |
| Pavese, P | 1 |
| Brion, JP | 1 |
| Lebeau, B | 1 |
| Grillot, R | 1 |
| Ambroise-Thomas, P | 1 |
| Krcmery, V | 2 |
| Sejnova, D | 2 |
| Pichnova, E | 2 |
| Moreno, M | 1 |
| Latorre, A | 1 |
| Manzanares, C | 1 |
| Morales, E | 1 |
| Herrero, JC | 1 |
| Dominguez-Gil, B | 1 |
| Carreño, A | 1 |
| Cubas, A | 1 |
| Delgado, M | 1 |
| Andres, A | 2 |
| Morales, JM | 2 |
| Krupova, Y | 1 |
| Dzatkova, J | 1 |
| Kaiserova, E | 1 |
| Kiskova, M | 1 |
| Babela, R | 1 |
| Mateicka, F | 1 |
| Sabo, A | 1 |
| Jurga, L | 1 |
| Sulcova, M | 1 |
| Willinger, B | 1 |
| Apfalter, P | 1 |
| Hirschl, AM | 1 |
| Makristathis, A | 1 |
| Rotter, M | 1 |
| Paterson, PJ | 1 |
| McWhinney, PH | 1 |
| Potter, M | 1 |
| Kibbler, CC | 1 |
| Prentice, HG | 1 |
| García, MT | 1 |
| Llorente, MT | 1 |
| Mínguez, F | 1 |
| Prieto, J | 1 |
| Samonis, G | 1 |
| Maraki, S | 1 |
| Hajiioannou, I | 1 |
| Chatzinikolaou, I | 1 |
| Rolston, KV | 1 |
| Kontoyiannis, DP | 1 |
| Walmsley, S | 1 |
| King, S | 1 |
| McGeer, A | 1 |
| Ye, Y | 1 |
| Richardson, S | 1 |
| Patton, LL | 1 |
| Bonito, AJ | 1 |
| Shugars, DA | 1 |
| Chiang, CT | 1 |
| Chan, HL | 1 |
| Barchiesi, F | 1 |
| Giacometti, A | 1 |
| Arzeni, D | 1 |
| Branchesi, P | 1 |
| Crescenzi, G | 1 |
| Ancarani, F | 1 |
| Scalise, G | 1 |
| Laine, L | 1 |
| Dretler, RH | 1 |
| Conteas, CN | 1 |
| Tuazon, C | 1 |
| Koster, FM | 1 |
| Sattler, F | 1 |
| Squires, K | 1 |
| Islam, MZ | 1 |
| Bhandari, V | 2 |
| Narang, A | 2 |
| Baran, R | 1 |
| van't Wout, JW | 3 |
| Eloy, O | 1 |
| Joly, V | 1 |
| Ghnassia, JC | 1 |
| Carbon, C | 1 |
| Yeni, P | 1 |
| Kumar, B | 1 |
| Singh, M | 1 |
| Nair, PM | 1 |
| Bhakoo, ON | 1 |
| Jamjoom, A | 1 |
| al-Abedeen Jamjoom, Z | 1 |
| al-Hedaithy, S | 1 |
| Jamali, A | 1 |
| Malabarey, T | 1 |
| Franco, A | 1 |
| Prados, MC | 1 |
| Perdiguero, M | 1 |
| Olivares, J | 1 |
| Miyasaki, SH | 1 |
| Hicks, JB | 1 |
| Greenspan, D | 1 |
| Polacheck, I | 1 |
| MacPhail, LA | 1 |
| White, TC | 1 |
| Agabian, N | 1 |
| Greenspan, JS | 1 |
| Lelarge, P | 1 |
| Mariot, J | 1 |
| Maskin, SL | 1 |
| Alfonso, E | 1 |
| Farias, J | 1 |
| Hernandez, G | 1 |
| Gomez, M | 1 |
| Calleja, J | 1 |
| Moreno, E | 1 |
| Rodicio, JL | 1 |
| Burton, DM | 1 |
| Seid, AB | 1 |
| Kearns, DB | 1 |
| Pransky, SM | 1 |
| Palmblad, J | 1 |
| Lönnqvist, B | 1 |
| Carlsson, B | 1 |
| Grimfors, G | 1 |
| Järnmark, M | 1 |
| Lerner, R | 1 |
| Ljungman, P | 1 |
| Nyström-Rosander, C | 1 |
| Petrini, B | 1 |
| Oberg, G | 1 |
| Cacciapuoti, A | 1 |
| Loebenberg, D | 1 |
| Parmegiani, R | 1 |
| Antonacci, B | 1 |
| Norris, C | 1 |
| Moss, EL | 1 |
| Menzel, F | 1 |
| Yarosh-Tomaine, T | 1 |
| Hare, RS | 1 |
| Miller, GH | 1 |
| Barantsevich, EP | 1 |
| Karaev, ZO | 1 |
| Pizarro, S | 1 |
| Barile, L | 1 |
| Fraga, A | 1 |
| Medina, F | 1 |
| Smith, DE | 1 |
| Midgley, J | 1 |
| Allan, M | 1 |
| Connolly, GM | 1 |
| Gazzard, BG | 1 |
| Novakova, I | 2 |
| Verhagen, CA | 2 |
| de Pauw, BE | 2 |
| Salavert, M | 1 |
| Carrasco, R | 1 |
| Roig, P | 1 |
| Nieto, A | 1 |
| Cervelló, A | 1 |
| Navarro, V | 1 |
| Angeli, A | 1 |
| Masera, RG | 1 |
| Gatti, G | 1 |
| Brusko, CS | 1 |
| Marten, JT | 1 |
| Knight, TE | 1 |
| Shikuma, CY | 1 |
| Knight, J | 1 |
| Kawasaki, K | 1 |
| Matsumura, Y | 1 |
| Ogawa, M | 1 |
| Tsuji, A | 1 |
| Matsunaga, T | 1 |
| Goto, S | 1 |
| Maĭchuk, IuF | 1 |
| Lapshina, NA | 1 |
| Diadina, UV | 1 |
| Gueteau, N | 1 |
| Darras, A | 1 |
| Croxo, C | 1 |
| Mulliez, P | 1 |
| St-Germain, G | 1 |
| Braunius, WW | 1 |
| Hartman, EG | 1 |
| van der Pol, R | 1 |
| Jacobs, PH | 1 |
| Nall, L | 1 |
| Yee, E | 1 |
| Meunier, F | 1 |
| Brod, RD | 1 |
| Flynn, HW | 1 |
| Clarkson, JG | 1 |
| Pflugfelder, SC | 1 |
| Culbertson, WW | 1 |
| Miller, D | 1 |
| Herrod, HG | 2 |
| Cohen, SR | 1 |
| Thompson, JW | 1 |
| Mobacken, H | 2 |
| Lindholm, L | 1 |
| Moberg, S | 2 |
| Dickneite, G | 1 |
| Schorlemmer, HU | 1 |
| Sedlacek, HH | 1 |
| Dompmartin, A | 1 |
| Houtteville, JP | 1 |
| Theron, J | 1 |
| Coldiron, BM | 1 |
| Bergstresser, PR | 1 |
| Van t Wout, JW | 1 |
| Mattie, H | 1 |
| van Furth, R | 1 |
| Nathwani, D | 1 |
| Green, ST | 1 |
| McGuire, W | 1 |
| Goldberg, DJ | 1 |
| Kennedy, DH | 1 |
| Burke, WA | 1 |
| Tindall, B | 1 |
| Hing, M | 1 |
| Edwards, P | 1 |
| Barnes, T | 1 |
| Mackie, A | 1 |
| Cooper, DA | 1 |
| Giménez-Esparza, JA | 1 |
| Gómez Trujillo, FM | 1 |
| Cárdenas Martínez, A | 1 |
| Juárez Fernández, C | 1 |
| Handrick, W | 1 |
| Schönborn, C | 1 |
| Spencker, FB | 1 |
| Hückel, D | 1 |
| Ray, TL | 1 |
| Zanetti, G | 1 |
| Calandra, T | 2 |
| de Muralt, B | 1 |
| Bille, J | 1 |
| Glauser, MP | 2 |
| McNulty, RM | 1 |
| Lazor, JA | 1 |
| Sketch, M | 1 |
| Cotton, MF | 1 |
| Ransome, OJ | 1 |
| Bannatyne, RM | 1 |
| Clarke, HM | 1 |
| Rietschel, P | 1 |
| VanEgmond, E | 1 |
| Lloyd, L | 1 |
| Rose, MH | 1 |
| Nobre, G | 1 |
| Mendes, E | 1 |
| Charrua, MJ | 1 |
| Cruz, O | 1 |
| Van Gerven, F | 2 |
| Janssen, PA | 3 |
| Hughes, CE | 2 |
| Bennett, RL | 1 |
| Tuna, IC | 1 |
| Beggs, WH | 2 |
| Santana, JL | 1 |
| Ramírez-Ronda, CH | 1 |
| Drew, RH | 1 |
| Perfect, JR | 3 |
| Gallis, HA | 1 |
| Vannimenus, PY | 1 |
| Hardouin, P | 1 |
| Thevenon, A | 1 |
| Walter, MP | 1 |
| Gluckman, E | 1 |
| Bauters, F | 1 |
| Herzog, W | 1 |
| Perfect, J | 1 |
| Roberts, L | 1 |
| Seebacher, C | 1 |
| Richardson, K | 2 |
| Brammer, KW | 2 |
| Marriott, MS | 2 |
| Troke, PF | 2 |
| Andrews, RJ | 1 |
| Savani, DV | 2 |
| Durack, DT | 2 |
| Smith, KJ | 1 |
| Hopwood, V | 1 |
| Vanden Bossche, H | 1 |
| Fransen, J | 2 |
| Cobo, LM | 1 |
| Yozwiak, ML | 1 |
| García, MP | 1 |
| Puig, L | 1 |
| Pérez, M | 1 |
| de Moragas, JM | 1 |
| Thamlikitkul, V | 1 |
| Danpakdi, K | 1 |
| Visuthisakchai, S | 1 |
| Kulpreedarat, T | 1 |
| Tanner, AR | 1 |
| Garavelli, PL | 1 |
| Michelone, G | 1 |
| Cavanna, C | 1 |
| Maccabruni, A | 1 |
| Naito, Y | 1 |
| Yoshikawa, T | 1 |
| Oyamada, H | 1 |
| Tainaka, K | 1 |
| Morita, Y | 1 |
| Kogawa, T | 1 |
| Sugino, S | 1 |
| Kondo, M | 1 |
| Swartz, DA | 1 |
| Harrington, P | 1 |
| Wilcox, R | 1 |
| Peppas, DS | 1 |
| Moul, JW | 1 |
| McLeod, DG | 1 |
| Li, YN | 1 |
| Shi, JQ | 1 |
| Huang, WM | 1 |
| Kovács, I | 1 |
| Szendei, G | 1 |
| Berbik, I | 1 |
| Deschamps, MM | 1 |
| Pape, JW | 1 |
| Verdier, RI | 1 |
| DeHovitz, J | 1 |
| Thomas, F | 1 |
| Johnson, WD | 1 |
| Arrieta Blanco, FJ | 1 |
| Saavedra Vallejo, MP | 1 |
| Tuñön Fernández, J | 1 |
| Marín Hernández, G | 1 |
| Aguirre Jaca, M | 1 |
| Bartkowski, DP | 1 |
| Lanesky, JR | 1 |
| Thaler, M | 1 |
| Bacher, J | 1 |
| O'Leary, T | 1 |
| Pizzo, PA | 1 |
| Clotet, B | 1 |
| Casals, A | 1 |
| Reverter, J | 1 |
| Planas, R | 1 |
| Boix, J | 1 |
| Gimenez, J | 1 |
| Jou, A | 1 |
| Tor, J | 1 |
| Foz, M | 1 |
| Minozzi, C | 1 |
| Decazes, JM | 1 |
| Vittecoq, D | 1 |
| De Roquancourt, A | 1 |
| Modai, J | 1 |
| Ruszinkó, B | 1 |
| Korányi, E | 1 |
| Török, I | 1 |
| Kottász, S | 1 |
| Brousil, E | 1 |
| Haron, E | 1 |
| Feld, R | 1 |
| Tuffnell, P | 1 |
| Patterson, B | 1 |
| Hasselback, R | 1 |
| Matlow, A | 1 |
| Lee, WM | 1 |
| Holley, HP | 1 |
| Stewart, J | 1 |
| Galbraith, GM | 1 |
| Goodman, DF | 1 |
| Stern, WH | 3 |
| Barrie, T | 2 |
| Malecaze, F | 1 |
| Linas, MD | 1 |
| Mathis, A | 1 |
| Arne, JL | 1 |
| Recco, P | 1 |
| Bessieres, MH | 1 |
| Bec, P | 1 |
| Tavitian, A | 1 |
| Raufman, JP | 1 |
| Rosenthal, LE | 1 |
| Weber, J | 1 |
| Webber, CA | 1 |
| Dincsoy, HP | 1 |
| Pruett, TL | 1 |
| Rotstein, OD | 1 |
| Anderson, RW | 1 |
| Meyer, RD | 1 |
| Brenciaglia, MI | 1 |
| Ghezzi, MC | 1 |
| Cipriani, P | 1 |
| Mancini, C | 1 |
| Trancassini, M | 1 |
| Montagnani, A | 1 |
| Negosanti, M | 1 |
| Patrizi, A | 1 |
| Peterson, LR | 1 |
| Gerding, DN | 1 |
| Ahonen, P | 1 |
| Myllärniemi, S | 1 |
| Kahanpää, A | 1 |
| Perheentupa, J | 1 |
| Pérez Suárez de Durandeau, L | 1 |
| Salinas Carmona, MC | 1 |
| Silva Siwady, JG | 1 |
| Hinojosa Ayala, JR | 1 |
| Slotman, GJ | 1 |
| Burchard, KW | 1 |
| Weiss, JL | 1 |
| Parker, WT | 1 |
| Hansen, RM | 1 |
| Reinerio, N | 1 |
| Sohnle, PG | 1 |
| Abrams, RA | 1 |
| Ritch, PS | 1 |
| Libnoch, JA | 1 |
| Anderson, T | 1 |
| Schønheyder, H | 1 |
| Brincker, H | 1 |
| Olsen, H | 1 |
| Stenderup, A | 1 |
| Guidat, JM | 1 |
| Saudax, E | 1 |
| Schmutz, JL | 1 |
| Flynn, PM | 1 |
| Barrett, FF | 1 |
| Leclerc, G | 1 |
| Weber, M | 1 |
| Contet-Audonneau, N | 1 |
| Beurey, J | 1 |
| Grubb, BP | 1 |
| Manders, MM | 1 |
| Haile, CA | 1 |
| Etienne, M | 1 |
| Nemery, A | 1 |
| Darcis, JM | 1 |
| Pierard, GE | 1 |
| Demonty, J | 1 |
| Quinn, JP | 1 |
| Venezio, FR | 1 |
| Balbi, C | 1 |
| D'Ajello, M | 1 |
| Balbi, GC | 1 |
| Pettit, JH | 1 |
| Kaufman, HE | 1 |
| Radetsky, M | 1 |
| Wheeler, RC | 1 |
| Roe, MH | 1 |
| Todd, JK | 1 |
| Ichise, K | 1 |
| Tanio, T | 1 |
| Saji, I | 1 |
| Okuda, T | 1 |
| Wengrower, D | 1 |
| Rave, D | 1 |
| Kleinman, Y | 1 |
| Cohen, PS | 1 |
| Scheer, RL | 1 |
| Bloom, MJ | 1 |
| Kolanchik, GJ | 1 |
| Tucker, JB | 1 |
| Smith, JM | 1 |
| Daugaard, K | 1 |
| Nielsen, H | 1 |
| Schiodt, M | 1 |
| Wheat, LJ | 1 |
| Slama, TG | 1 |
| Zeckel, ML | 1 |
| Servant, JB | 1 |
| Dutton, GN | 1 |
| Ong-Tone, L | 1 |
| Davey, C | 1 |
| Vogt, M | 1 |
| Lüthy, R | 1 |
| Bircher, A | 1 |
| Furger, F | 1 |
| Lang, W | 1 |
| Maurer, R | 1 |
| Siegenthaler, W | 1 |
| Berkowitz, RJ | 1 |
| Hughes, C | 1 |
| Rudnick, M | 1 |
| Gordon, EM | 1 |
| Strandjord, S | 1 |
| Cheung, NK | 1 |
| Warkentin, P | 1 |
| Coccia, PF | 1 |
| Weber, MJ | 1 |
| Keppen, M | 1 |
| Gawith, KE | 1 |
| Epstein, RB | 1 |
| Lüdin, E | 1 |
| Shepp, DH | 1 |
| Klosterman, A | 1 |
| Siegel, MS | 1 |
| Meyers, JD | 1 |
| Parkin, JL | 1 |
| Vargas-Origel, A | 1 |
| Rodríguez-Cámara, A | 1 |
| Aldana-Valenzuela, C | 1 |
| Manjarrez-Gutiérrez, G | 1 |
| Abdo-Bassol, F | 1 |
| Burnie, JP | 1 |
| Lee, W | 1 |
| Williams, JD | 1 |
| Matthews, RC | 1 |
| Selkin, SG | 1 |
| Ahmad, S | 1 |
| Boone, D | 1 |
| Hall, D | 1 |
| Cole, JJ | 1 |
| Dennis, MB | 1 |
| Haddy, RI | 1 |
| Petry, LJ | 1 |
| Bond, JA | 1 |
| Shelton, JA | 1 |
| Day, CM | 1 |
| Curry, RW | 1 |
| Bidgood, WD | 1 |
| Haas, A | 1 |
| Goldberg, PE | 1 |
| Lefler, E | 1 |
| Stevens, DA | 1 |
| Fisher, JF | 1 |
| Henson, DM | 1 |
| Freeman, JM | 1 |
| Seeliger, HP | 1 |
| Wehrspann, P | 1 |
| Füllbrandt, U | 1 |
| Francioli, P | 1 |
| Baudraz-Rosselet, F | 1 |
| Ruffieux, C | 1 |
| Grigoriu, D | 1 |
| Farkas, B | 1 |
| Karácsonyi, G | 1 |
| Podzamczer, D | 1 |
| Fernández-Viladrich, P | 1 |
| Ribera, M | 1 |
| Arruga, J | 1 |
| de Celis, G | 1 |
| Gudiol, F | 1 |
| Ho, NK | 1 |
| Katzenstein, D | 1 |
| Tamura, E | 1 |
| Jacobs, RA | 1 |
| Pons, VG | 1 |
| Stone, RD | 1 |
| Irvine, AR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Comparative Multicenter Trial of Fluconazole and Ketoconazole in the Treatment of Esophageal Candidiasis in Immunocompromised Patients[NCT00002304] | 0 participants | Interventional | Completed | ||||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
25 reviews available for ketoconazole and Candidiasis
| Article | Year |
|---|---|
Antifungal pharmacotherapy for neonatal candidiasis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Cross Infection; Echinocandins; Flucona | 2003 |
[Imidazole preparations in mycology].
Topics: Animals; Antifungal Agents; Candidiasis; Clotrimazole; Coccidioidomycosis; Cryptococcosis; Dermatomy | 1984 |
Current management of fungal enteritis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Diarrhea; Enteritis; Histoplasmosis; Humans; Imidazo | 1982 |
Current therapy of pulmonary and disseminated fungal diseases.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Chromoblastomycosis; C | 1983 |
Symposium on infectious complications of neoplastic disease (Part II). Chemoprophylaxis of fungal infections.
Topics: Administration, Oral; Administration, Topical; Amphotericin B; Antifungal Agents; Candidiasis; Clini | 1984 |
Ketoconazole.
Topics: Candidiasis; Candidiasis, Chronic Mucocutaneous; Candidiasis, Oral; Chemical Phenomena; Chemistry; C | 1984 |
[Therapy of candidiasis and cryptococcosis in AIDS].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Candidiasis, Oral; Cryptococc | 1994 |
Can we prevent azole resistance in fungi?
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Candida; Candidiasis; Drug Resista | 1995 |
Fungal peritonitis in patients on peritoneal dialysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Drug Administ | 1994 |
Itraconazole and fluconazole in oropharyngeal candidiasis.
Topics: Antifungal Agents; Candidiasis; Candidiasis, Oral; Fluconazole; Humans; Itraconazole; Ketoconazole; | 1993 |
Azole resistance in Candida.
Topics: Antifungal Agents; Azoles; Candidiasis; Drug Resistance, Microbial; Fluconazole; Humans; Ketoconazol | 1997 |
[Prevention and treatment of invasive mycoses in patients with neutropenia and bone marrow transplantation].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Candidia | 1995 |
[Diagnosis, treatment and prevention of infections caused by fungi in HIV-positive patients].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Cand | 1995 |
[Antifungal agent resistance of yeasts of clinical significance].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Candida albicans; Candidiasis; Dru | 1995 |
[Commonly used antifungal agents in the treatment of systemic mycoses].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Clinical Trials as Top | 1995 |
A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candidiasis; Candidiasis, | 2001 |
Superficial mycosis superimposing on isolated lichen planus of the lip: a case report and review of the literature.
Topics: Adult; Anti-Inflammatory Agents; Antifungal Agents; Candidiasis; Diagnosis, Differential; Female; Gr | 2002 |
[Choice and monitoring of the treatment of systemic mycoses. Value and limitations of in vitro tests].
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Th | 1992 |
[Systemic candidiasis].
Topics: Amphotericin B; Candida; Candidiasis; Decontamination; Drug Therapy, Combination; Female; Flucytosin | 1992 |
[Mycoses and adrenocortical function. New pathogenetic aspects of adrenal hypofunction].
Topics: Acquired Immunodeficiency Syndrome; Adrenal Cortex Hormones; Adrenal Glands; Adrenal Insufficiency; | 1991 |
Ketoconazole hepatotoxicity in a patient treated for environmental illness and systemic candidiasis.
Topics: Adult; Candidiasis; Chemical and Drug Induced Liver Injury; Environmental Exposure; Environmental Po | 1991 |
Ketoconazole-induced fulminant hepatitis necessitating liver transplantation.
Topics: Candidiasis; Chemical and Drug Induced Liver Injury; Female; Humans; Ketoconazole; Liver Transplanta | 1991 |
[Systemic mycotic infections].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Fluconazole; Humans; | 1990 |
Systemic candidiasis.
Topics: Amphotericin B; Candidiasis; Flucytosine; Humans; Immune Tolerance; Ketoconazole; Neoplasms; Opportu | 1989 |
Cutaneous and mucosal manifestations of the deep mycotic infections.
Topics: Amphotericin B; Aspergillosis; Blastomycosis; Candidiasis; Candidiasis, Cutaneous; Coccidioidomycosi | 1986 |
30 trials available for ketoconazole and Candidiasis
| Article | Year |
|---|---|
Comparative efficacy of topical therapy with a slow-release mucoadhesive buccal tablet containing miconazole nitrate versus systemic therapy with ketoconazole in HIV-positive patients with oropharyngeal candidiasis.
Topics: Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasi | 2004 |
[Comparison of efficacy of combination of ketokonazol 400 mg + clindamycin 100 mg with ketokonazol 800 mg + clindamycin 100 mg in the treatment of vaginitis due to Candida and bacterial vaginosis].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Clindamycin; Double-Blind | 2005 |
Value of colposcopy in the diagnosis of candidiasis in patients with vulvodynia.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candidiasis; Colposcopy; Female; Fluconazole; Humans; Ke | 2007 |
Treatment and prevention of oropharyngeal candidiasis.
Topics: Adolescent; Adult; Aged; Aspergillosis; Candidiasis; Child; Child, Preschool; Clinical Trials as Top | 1984 |
Treatment of paracoccidioidomycosis, candidiasis, chromomycosis, lobomycosis, and mycetoma with ketoconazole.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candidiasis; Chromoblastomycosis; Clinical Trials as Top | 1980 |
Successful treatment of chronic mucocutaneous candidiasis with ketoconazole.
Topics: Adult; Antifungal Agents; Candida; Candidiasis; Candidiasis, Chronic Mucocutaneous; Child; Clinical | 1980 |
Treatment of chronic mucocutaneous candidiasis with ketoconazole: a controlled clinical trial.
Topics: Adolescent; Adult; Candidiasis; Candidiasis, Chronic Mucocutaneous; Child; Clinical Trials as Topic; | 1980 |
Ketoconazole: a major innovation for treatment of fungal disease.
Topics: Animals; Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Clinical Trials as Topi | 1980 |
A multicenter double-blind evaluation of ketoconazole in the treatment of dermatomycoses.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candidiasis; Chemical and Drug Induced Liver Injury; Chi | 1983 |
Oral prophylaxis with miconazole or ketoconazole of invasive fungal disease in neutropenic cancer patients.
Topics: Agranulocytosis; Antifungal Agents; Candidiasis; Drug Combinations; Female; Humans; Imidazoles; Keto | 1983 |
Prophylaxis of fungal infections in neutropenic cancer patients.
Topics: Agranulocytosis; Amphotericin B; Aspergillosis; Candidiasis; Clinical Trials as Topic; Humans; Ketoc | 1983 |
Symposium on infectious complications of neoplastic disease (Part II). Chemoprophylaxis of fungal infections.
Topics: Administration, Oral; Administration, Topical; Amphotericin B; Antifungal Agents; Candidiasis; Clini | 1984 |
Salivary concentrations of ketoconazole and fluconazole: implications for drug efficacy in oropharyngeal and esophageal candidiasis.
Topics: Administration, Oral; Adult; Candida albicans; Candidiasis; Chromatography, High Pressure Liquid; Cr | 1995 |
Prevention of symptomatic recurrences of esophageal candidiasis in AIDS patients after the first episode: a prospective open study.
Topics: Adult; AIDS-Related Opportunistic Infections; Candidiasis; Esophagitis; Female; Fluconazole; Follow- | 1994 |
Routine prophylactic antifungal agents (clotrimazole, ketoconazole, and nystatin) in nontransplant/nonburned critically ill surgical and trauma patients.
Topics: Aged; Candida; Candidiasis; Clotrimazole; Colony Count, Microbial; Critical Illness; Cross Infection | 1994 |
Fluconazole compared with ketoconazole for the treatment of Candida esophagitis in AIDS. A randomized trial.
Topics: Acquired Immunodeficiency Syndrome; Adult; Candidiasis; Double-Blind Method; Esophagitis; Esophagosc | 1992 |
Itraconazole in neutropenic patients.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Humans; Itraconazole; Ketoconazole; M | 1992 |
Opportunistic fungal infections in patients with acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Candidiasis; Cryptococcosis; Double-Blind Met | 1992 |
Oral ketoconazole prophylaxis for Candida infections during induction therapy for acute leukaemia in adults: more bacteraemias.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Candidiasis; Humans; Incidence; Ketocona | 1992 |
Itraconazole versus ketaconazole in the treatment of oral and oesophageal candidosis in patients infected with HIV.
Topics: Antifungal Agents; Candidiasis; Candidiasis, Oral; Double-Blind Method; Esophageal Diseases; Female; | 1991 |
[Therapy of systemic mycoses in neutropenic patients using itraconazole. A comparative, randomized study with amphotericin B].
Topics: Adolescent; Agranulocytosis; Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmo | 1991 |
The efficacy of itraconazole against systemic fungal infections in neutropenic patients: a randomised comparative study with amphotericin B.
Topics: Amphotericin B; Aspergillosis; Aspergillus fumigatus; Candidiasis; Drug Therapy, Combination; Female | 1991 |
[Imidazoles in the treatment of ocular mycoses].
Topics: Administration, Oral; Aspergillosis; Candidiasis; Eye Infections, Fungal; Humans; Ketoconazole; Opht | 1991 |
Randomized controlled trial of clotrimazole troche and ketoconazole for oropharyngeal candidiasis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Candidiasis; Clinical Trials as Topic; Clotrimazole; | 1988 |
Ketoconazole treatment of 13 patients with chronic mucocutaneous candidiasis. A prospective 3-year trial.
Topics: Administration, Oral; Adolescent; Adult; Candidiasis; Candidiasis, Chronic Mucocutaneous; Child; Chi | 1986 |
Treatment of candida esophagitis in AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Candidiasis; Clinical Trials as Top | 1988 |
Ketoconazole is effective against the chronic mucocutaneous candidosis of autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy (APECED).
Topics: Adolescent; Adrenal Insufficiency; Adult; Autoimmune Diseases; Candidiasis; Candidiasis, Chronic Muc | 1986 |
Ketoconazole prevents Candida sepsis in critically ill surgical patients.
Topics: Adult; Candidiasis; Clinical Trials as Topic; Critical Care; Double-Blind Method; Humans; Ketoconazo | 1987 |
Ketoconazole in the prevention of candidiasis in patients with cancer. A prospective, randomized, controlled, double-blind study.
Topics: Candidiasis; Candidiasis, Oral; Clinical Trials as Topic; Double-Blind Method; Humans; Immunosuppres | 1987 |
Comparative trial of ketoconazole and nystatin for prevention of fungal infection in neutropenic patients treated in a protective environment.
Topics: Agranulocytosis; Candida albicans; Candidiasis; Clinical Trials as Topic; Environment, Controlled; H | 1985 |
298 other studies available for ketoconazole and Candidiasis
| Article | Year |
|---|---|
Antimycotic imidazoles. part 4. Synthesis and antifungal activity of ketoconazole, a new potent orally active broad-spectrum antifungal agent.
Topics: Animals; Antifungal Agents; Candidiasis; Chemical Phenomena; Chemistry; Female; Guinea Pigs; Imidazo | 1979 |
Studies on antifungal agents. 23. Novel substituted 3,5-diphenyl-3-(1H-imidazol-1-ylmethyl)- 2-alkylisoxazolidine derivatives.
Topics: Animals; Antifungal Agents; Candidiasis; Imidazoles; Isoxazoles; Ketoconazole; Magnetic Resonance Sp | 1988 |
Synthesis and oral antifungal activity of novel azolylpropanolones and related compounds.
Topics: 1-Propanol; Administration, Oral; Animals; Antifungal Agents; Azoles; Candidiasis; Female; Guinea Pi | 1987 |
Antifungal agents. 9. 3-Aryl-4-[alpha-(1H-imidazol-1-yl)arylmethyl]pyrroles: a new class of potent anti-Candida agents.
Topics: Adult; Animals; Antifungal Agents; Candida; Candida albicans; Candidiasis; Drug Resistance, Microbia | 1995 |
Synthesis and antifungal activity of new azole derivatives containing an N-acylmorpholine ring.
Topics: Animals; Antifungal Agents; Azoles; Candidiasis; Female; Male; Mice; Microbial Sensitivity Tests; Ra | 1995 |
Reduced susceptibility to polyenes associated with a missense mutation in the ERG6 gene in a clinical isolate of Candida glabrata with pseudohyphal growth.
Topics: Antifungal Agents; Candida glabrata; Candidiasis; DNA Primers; Genes, Fungal; Genetic Complementatio | 2007 |
Synthesis and antifungal activities of novel 2-aminotetralin derivatives.
Topics: Administration, Intravaginal; Animals; Antifungal Agents; Binding Sites; Candida albicans; Candidias | 2007 |
A nonsense mutation in the ERG6 gene leads to reduced susceptibility to polyenes in a clinical isolate of Candida glabrata.
Topics: Antifungal Agents; Azoles; Base Sequence; Candida glabrata; Candidiasis; Codon, Nonsense; DNA, Funga | 2008 |
Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Blotting | 2009 |
Synthesis and antifungal activity of 1,2,3-triazole containing fluconazole analogues.
Topics: Animals; Antifungal Agents; Bile Acids and Salts; Candida albicans; Candidiasis; Cell Line, Tumor; C | 2009 |
New small-size peptides possessing antifungal activity.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; Candida albicans; Candidiasis; Cryptococcosis; Cryp | 2010 |
Synthesis and antimicrobial evaluation of new benzofuran derivatives.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacillus subtilis; Bacterial Infections; Benzofurans; Cand | 2011 |
Formulation, Optimization and Evaluation of Novel Ultra-deformable Vesicular Drug Delivery System for an Anti-fungal Drug.
Topics: Administration, Cutaneous; Animals; Antifungal Agents; Candidiasis; Drug Compounding; Drug Delivery | 2020 |
High frequency of azole resistant Candida spp. colonization among presumptive multidrug resistant tuberculosis (MDR-TB) patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Antitubercular Agents; Candida; Candi | 2020 |
Multifactorial Mechanisms of Tolerance to Ketoconazole in Candida albicans.
Topics: Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B; Candida albicans; Candidiasis; Dru | 2021 |
Candidiasis: Prevalence and resistance profiling in a tertiary care hospital of Pakistan.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis; Cross-Sectional | 2017 |
Functions of CaPhm7 in the regulation of ion homeostasis, drug tolerance, filamentation and virulence in Candida albicans.
Topics: Animals; Candida albicans; Candidiasis; Disease Models, Animal; Drug Resistance, Fungal; Fungal Prot | 2018 |
Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain in 2010 and 2011.
Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Dru | 2014 |
Tricky triggers of intertrigo.
Topics: Acyclovir; Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Antiviral Agents; Candidiasis; C | 2014 |
Effects of rifampin and ketoconazole on pharmacokinetics of morinidazole in healthy chinese subjects.
Topics: Animals; Antifungal Agents; Candida glabrata; Candidiasis; Cell Line; Female; Fluconazole; Fungal Pr | 2014 |
Impact of brief and sequential exposure to nystatin, amphotericin B, ketoconazole, and fluconazole in modulating adhesion traits of oral Candida dubliniensis isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Epithelial Cells; Fluconazole; Humans; Keto | 2016 |
The anti-candidal activity of Satureja khuzistanica ethanol extract against clinical isolates of C. albicans.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis | 2016 |
Inhibiting fungal multidrug resistance by disrupting an activator-Mediator interaction.
Topics: Animals; Antifungal Agents; Binding Sites; Candida glabrata; Candidiasis; DNA-Binding Proteins; Drug | 2016 |
Susceptibility to voriconazole, fluconazole, and ketoconazole of yeast isolated from patients with hematological malignancies.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Hematologic Neoplasms | 2008 |
Direct antifungal susceptibility testing of positive Candida blood cultures by sensititre YeastOne.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucy | 2009 |
In vitro investigation of antifungal activity of allicin alone and in combination with azoles against Candida species.
Topics: Antifungal Agents; Azoles; Candida; Candidiasis; Disulfides; Drug Synergism; Fluconazole; Humans; Ke | 2010 |
Candida albicans enhances experimental hepatic melanoma metastasis.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Humans; Inflammation Mediators; Interleuk | 2010 |
The post-antifungal effect (PAFE) of amphotericin B, nystatin, ketoconazole and 5-fluorocytosine and its impact on the colonization traits of Candida glabrata.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Biomass; Candida glabrata; Candidiasis; Cell Adhesion; | 2010 |
Changes in the proteome of Candida albicans in response to azole, polyene, and echinocandin antifungal agents.
Topics: Adaptation, Physiological; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Caspofu | 2010 |
[Management of invasive fungal infections in children].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Child; Echinocandins; Humans; Ketoconazole; Mycoses; | 2011 |
Retigeric acid B enhances the efficacy of azoles combating the virulence and biofilm formation of Candida albicans.
Topics: Animals; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biofilms; Caco- | 2012 |
Synthesis of novel water soluble benzylazolium prodrugs of lipophilic azole antifungals.
Topics: Animals; Antifungal Agents; Aspergillus fumigatus; Azoles; Candida albicans; Candidiasis; Chemical P | 2002 |
Prevalence and antifungal susceptibilities of yeast isolates during one year at a university hospital in Turkey.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Multiple, Fungal; Fluconaz | 2002 |
Pulmonary candidiasis caused by Candida albicans in a Greek tortoise (Testudo graeca) and treatment with intrapulmonary amphotericin B.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Female; Infusions, Intralesional; Ketoconaz | 2001 |
Fungal infection of sutureless self-sealing incision for cataract surgery.
Topics: Aged; Aged, 80 and over; Amphotericin B; Aspergillosis; Candidiasis; Corneal Ulcer; Drug Therapy, Co | 2003 |
Antifungal susceptibility of 50 Candida isolates from invasive mycoses in Chile.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis; Chile; | 2004 |
Refractory anaphylactic shock associated with ketoconazole treatment.
Topics: Aged; Anaphylaxis; Antifungal Agents; Candidiasis; Eye Infections, Fungal; Female; Humans; Hypotensi | 2005 |
Increased expression and hotspot mutations of the multidrug efflux transporter, CDR1 in azole-resistant Candida albicans isolates from vaginitis patients.
Topics: Antifungal Agents; Base Sequence; Candida albicans; Candida glabrata; Candidiasis; Clotrimazole; DNA | 2005 |
Novel ketoconazole analogues based on the replacement of 2,4-dichlorophenyl group with 1,4-benzothiazine moiety: design, synthesis, and microbiological evaluation.
Topics: Animals; Candida albicans; Candidiasis; Crystallography, X-Ray; Cytochrome P-450 Enzyme Inhibitors; | 2006 |
[The sensitivity to ketoconazole of Candida strains isolated from the digestive tract ontocenoses in children].
Topics: Antifungal Agents; Candida; Candidiasis; Child; Female; Gastrointestinal Tract; Humans; Ketoconazole | 2001 |
Identification and in vitro antifungal susceptibility testing of 200 clinical isolates of Candida spp. responsible for fingernail infections.
Topics: Antifungal Agents; Brazil; Candida; Candidiasis; Ciclopirox; Fluconazole; Hand Dermatoses; Humans; I | 2007 |
Candida interface keratitis after deep anterior lamellar keratoplasty: clinical, microbiologic, histopathologic, and confocal microscopic reports.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis; Cornea; C | 2007 |
[Itraconazole treatment in the suspension of pathological fungal colonization of the airway in patients with pulmonary tuberculosis].
Topics: Antifungal Agents; Antitubercular Agents; Candida albicans; Candidiasis; Fungi; Humans; Itraconazole | 2008 |
Pyothorax caused by Candida albicans in a cat.
Topics: Animals; Candidiasis; Cat Diseases; Cats; Empyema; Ketoconazole | 1984 |
[Ketoconazole and onychomycosis].
Topics: Adolescent; Adult; Aged; Arthrodermataceae; Candidiasis; Female; Foot Dermatoses; Hand Dermatoses; H | 1984 |
Candidiasis in cancer patients.
Topics: Amphotericin B; Antibodies, Fungal; Candidiasis; Cephalosporins; Humans; Ketoconazole; Leukemia; Mic | 1984 |
Systemic candidiasis in cancer patients.
Topics: Acute Disease; Amphotericin B; Bacterial Infections; Bacteriological Techniques; Candida; Candidiasi | 1984 |
Oral ketoconazole therapy for experimental candida albicans keratitis in rabbits.
Topics: Administration, Oral; Animals; Candidiasis; Cornea; Female; Keratitis; Ketoconazole; Male; Rabbits; | 1984 |
Pharmacokinetics of ketoconazole and treatment evaluation in candidal infections.
Topics: Adolescent; Candida albicans; Candidiasis; Child; Child, Preschool; Drug Administration Schedule; Fe | 1984 |
Immunological observations before and after successful treatment of chronic mucocutaneous candidiasis with ketoconazole and transfer factor.
Topics: Antibody Formation; Candida albicans; Candidiasis; Candidiasis, Chronic Mucocutaneous; Chemotaxis, L | 1984 |
Candidiasis in captive pinnipeds.
Topics: Animals; Animals, Wild; Birds; Candida albicans; Candidiasis; Candidiasis, Chronic Mucocutaneous; Ca | 1984 |
Candidiasis.
Topics: Amphotericin B; Candidiasis; Child, Preschool; Female; Humans; Infant; Ketoconazole; Male | 1984 |
Relationship between serotype, sensitivity to ketoconazole and inhibition of pseudomycelial growth in Candida albicans.
Topics: Candida albicans; Candidiasis; Drug Resistance, Microbial; Fluorescent Antibody Technique; Humans; K | 1984 |
[Severe candidiasis in heroin addicts].
Topics: Abscess; Adolescent; Adult; Candidiasis; Eye Diseases; Female; Hair Diseases; Heroin Dependence; Hum | 1984 |
Ketoconazole and the liver.
Topics: Candidiasis; Chemical and Drug Induced Liver Injury; Humans; Imidazoles; Ketoconazole; Piperazines | 1982 |
Ketoconazole, cyclosporin metabolism, and renal transplantation.
Topics: Antifungal Agents; Candidiasis; Cyclosporins; Drug Interactions; Female; Humans; Imidazoles; Ketocon | 1982 |
Ketoconazole in a case of chronic mucocutaneous candidiasis.
Topics: Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Child; Child, Preschool; Female; | 1982 |
Chronic mucocutaneous candidiasis with IgA deficiency in a two-year-old African girl who responded well to ketoconazole.
Topics: Candidiasis; Candidiasis, Chronic Mucocutaneous; Child, Preschool; Dysgammaglobulinemia; Facial Derm | 1983 |
[Therapy of genital contact infections].
Topics: Amantadine; Anti-Bacterial Agents; Candidiasis; Carbaryl; Condylomata Acuminata; Female; Genital Dis | 1983 |
The activity in vitro and in vivo of a new imidazole antifungal, ketoconazole.
Topics: Animals; Antifungal Agents; Arthrodermataceae; Aspergillus; Candidiasis; Dermatomycoses; Fungi; Guin | 1980 |
CSF concentrations of ketoconazole.
Topics: Candidiasis; Humans; Imidazoles; Ketoconazole; Male; Meningitis; Middle Aged; Piperazines | 1980 |
Ketoconazole treatment of chronic mucocutaneous candidiasis.
Topics: Adolescent; Adult; Candidiasis; Candidiasis, Chronic Mucocutaneous; Candidiasis, Oral; Cryptococcosi | 1980 |
Relapse of Candida parapsilosis endocarditis after long-term suppression with flucytosin: retreatment with valve replacement and ketoconazole.
Topics: Adult; Amphotericin B; Candidiasis; Cytosine; Drug Therapy, Combination; Endocarditis; Female; Flucy | 1980 |
Familial chronic mucocutaneous candidiasis successfully treated with oral ketoconazole.
Topics: Administration, Oral; Adult; Candidiasis; Candidiasis, Chronic Mucocutaneous; Candidiasis, Oral; Hum | 1981 |
[Ketoconazole a new broad spectrum antimycotic].
Topics: Adolescent; Adult; Aged; Candida; Candidiasis; Child; Female; Humans; Imidazoles; Ketoconazole; Mala | 1980 |
Chronic mucocutaneous candidiasis with a serum-dependent neutrophil defect: response to ketoconazole.
Topics: Adult; Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Female; Humans; Imidazole | 1981 |
Miconazole therapy for keratomycosis.
Topics: Adult; Aged; Aspergillosis; Candidiasis; Corneal Diseases; Female; Humans; Imidazoles; Keratitis; Ke | 1981 |
Chemotherapy of experimental endogenous Candida albicans endophthalmitis.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Disease Models, Animal; Drug Therapy, Combi | 1980 |
[Fungal infections -- always dangerous for immunosuppressed patients (author's transl)].
Topics: Adult; Candidiasis; Female; Humans; Imidazoles; Immunosuppression Therapy; Ketoconazole; Kidney Tran | 1981 |
Endogenous Candida albicans endophthalmitis in the rabbit. Chemotherapy for systemic effect.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Endophthalmitis; Imidazoles; Injections, In | 1981 |
The treatment of patients with chronic mucocutaneous candidosis and candida onychomycosis with ketoconazole.
Topics: Candidiasis; Candidiasis, Chronic Mucocutaneous; Humans; Imidazoles; Ketoconazole; Piperazines | 1982 |
Severe hepatitis associated with ketoconazole therapy for chronic mucocutaneous candidiasis.
Topics: Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Chemical and Drug Induced Liver | 1982 |
The outlook for antifungal prophylaxis in the compromised host.
Topics: Candidiasis; Humans; Imidazoles; Immunity; Ketoconazole; Miconazole; Mycoses; Neoplasms; Nystatin; P | 1982 |
Therapy of superficial fungal infection.
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Candidiasis; Candidiasis, Oral; Dermatomyco | 1982 |
Ketoconazole in the treatment of chronic mucocutaneous candidiasis secondary to autoimmune polyendocrinopathy-candidiasis syndrome.
Topics: Adolescent; Antifungal Agents; Autoimmune Diseases; Candidiasis; Candidiasis, Chronic Mucocutaneous; | 1982 |
Apparent ketoconazole failure in candidal cholecystitis.
Topics: Antifungal Agents; Candidiasis; Cholecystitis; Humans; Imidazoles; Ketoconazole; Male; Middle Aged; | 1982 |
Successful treatment of chronic esophageal candidosis with oral ketoconazole.
Topics: Administration, Oral; Aged; Antifungal Agents; Candidiasis; Chronic Disease; Esophageal Diseases; Hu | 1982 |
Chronic mucocutaneous candidiasis treated with ketoconazole.
Topics: Candidiasis; Candidiasis, Chronic Mucocutaneous; Child; Humans; Imidazoles; Infant; Ketoconazole; Ma | 1982 |
Candidiasis in captive cetaceans.
Topics: Animals; Candidiasis; Cetacea; Female; Imidazoles; Ketoconazole; Levamisole; Male; Piperazines | 1982 |
A treatment regimen for candidiasis in an Atlantic bottlenose dolphin.
Topics: Animals; Candidiasis; Dolphins; Female; Imidazoles; Ketoconazole; Piperazines | 1982 |
Oral antifungal therapy. Current status of ketoconazole.
Topics: Administration, Oral; Antifungal Agents; Candidiasis; Coccidioidomycosis; Histoplasmosis; Humans; Im | 1983 |
Ketoconazole in the treatment of fungal infection. Clinical and laboratory studies.
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Dermatomycose | 1983 |
Therapy of chronic mucocutaneous candidiasis.
Topics: Adult; Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Child; Drug Administratio | 1983 |
Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole: experience with twenty-one patients.
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Chemical and | 1983 |
Laboratory and clinical assessment of ketoconazole in deep-seated mycoses.
Topics: Adolescent; Adult; Antifungal Agents; Arthritis, Infectious; Blastomycosis; Candidiasis; Candidiasis | 1983 |
Potential and problems with ketoconazole.
Topics: Antifungal Agents; Candidiasis; Chemical and Drug Induced Liver Injury; Coccidioidomycosis; Endocrin | 1983 |
Treatment of mycoses in cancer patients.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Candidiasis, Oral; Drug Therapy, Comb | 1983 |
The antifungal activity of ketoconazole.
Topics: Administration, Oral; Animals; Antifungal Agents; Candidiasis; Candidiasis, Cutaneous; Candidiasis, | 1983 |
Systemic candidiasis.
Topics: Antifungal Agents; Candidiasis; Humans; Imidazoles; Infant, Newborn; Infant, Newborn, Diseases; Keto | 1982 |
Ketoconazole therapy and exfoliative erythroderma.
Topics: Candidiasis; Dermatitis, Exfoliative; Drug Eruptions; Graft Rejection; Humans; Imidazoles; Ketoconaz | 1983 |
Combination therapy of experimental candidiasis, cryptococcosis and aspergillosis in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Synergi | 1982 |
Clinical presentation of candidal balanitis--its differential diagnosis and treatment.
Topics: Antifungal Agents; Balanitis; Candidiasis; Diagnosis, Differential; Humans; Imidazoles; Ketoconazole | 1982 |
Intermittent ketoconazole therapy of chronic mucocutaneous candidiasis in childhood.
Topics: Administration, Oral; Adolescent; Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous | 1982 |
Ketoconazole therapy for fungal urinary tract infections.
Topics: Adult; Antifungal Agents; Candida; Candidiasis; Female; Humans; Imidazoles; Ketoconazole; Male; Myco | 1983 |
Severe chronic mucocutaneous candidiasis. Favourable response to oral therapy with ketoconazole.
Topics: Adolescent; Body Height; Candidiasis; Candidiasis, Chronic Mucocutaneous; Esophageal Stenosis; Human | 1983 |
Candida peritonitis in children on continuous ambulatory peritoneal dialysis.
Topics: Amphotericin B; Candidiasis; Catheterization; Child, Preschool; Female; Humans; Imidazoles; Infant; | 1982 |
Control of systemic spread of Candida albicans with ketoconazole in the stomachs of mice treated with cytarabine.
Topics: Animals; Animals, Newborn; Antifungal Agents; Candidiasis; Cytarabine; Female; Imidazoles; Ketoconaz | 1983 |
[Therapy of a Candida infection with ketoconazole].
Topics: Aged; Antifungal Agents; Candidiasis; Female; Humans; Imidazoles; Ketoconazole; Piperazines; Sepsis | 1983 |
Neonatal systemic candidiasis treated with miconazole and ketoconazole.
Topics: Candidiasis; Female; Humans; Imidazoles; Infant, Newborn; Infant, Newborn, Diseases; Ketoconazole; M | 1983 |
[Ketoconazole].
Topics: Antifungal Agents; Candidiasis; Humans; Imidazoles; Ketoconazole; Kinetics; Piperazines | 1982 |
Ketoconazole treatment of Candida esophagitis--a prospective study of 12 cases.
Topics: Adult; Aged; Candidiasis; Endoscopy; Esophagitis; Female; Humans; Imidazoles; Ketoconazole; Male; Mi | 1983 |
Late-onset chronic mucocutaneous and ocular candidiasis and malignant thymoma.
Topics: Candidiasis; Candidiasis, Chronic Mucocutaneous; Conjunctival Diseases; Humans; Imidazoles; Ketocona | 1983 |
[1 1/2 years' experience with ketoconazol - report of results].
Topics: Antifungal Agents; Candidiasis; Dermatomycoses; Female; Humans; Imidazoles; Ketoconazole; Male; Myco | 1983 |
Esophageal candidiasis: treatment with ketoconazole.
Topics: Administration, Oral; Adult; Candidiasis; Child; Esophageal Diseases; Female; Humans; Ketoconazole; | 1983 |
[Treatment of severe Candida infections with ketoconazole in newborn and young infants].
Topics: Candida albicans; Candidiasis; Candidiasis, Cutaneous; Candidiasis, Oral; Humans; Infant; Infant, Ne | 1983 |
[Effects of oral ketoconazole in experimental fungal keratitis].
Topics: Administration, Oral; Animals; Candidiasis; Keratitis; Ketoconazole; Rabbits | 1983 |
[Malignant hemangiopericytoma. Candida meningitis under ketoconazole therapy].
Topics: Adult; Candidiasis; Female; Hemangiopericytoma; Humans; Ketoconazole; Leukopenia; Meningitis; Neopla | 1983 |
Persistent oesophageal candidiasis treated with ketoconazole.
Topics: Candidiasis; Esophagitis; Humans; Ketoconazole; Male; Middle Aged | 1983 |
Ketoconazole treatment of nail infection in chronic mucocutaneous candidiasis.
Topics: Adolescent; Candidiasis; Candidiasis, Chronic Mucocutaneous; Child; Child, Preschool; Female; Humans | 1983 |
Chronic mucocutaneous candidiasis.
Topics: Candidiasis; Candidiasis, Chronic Mucocutaneous; Candidiasis, Oral; Clotrimazole; Humans; Infant; Ke | 1983 |
Re: Ketoconazole therapy for fungal urinary tract infections.
Topics: Candidiasis; Catheters, Indwelling; Humans; Ketoconazole; Urinary Catheterization; Urinary Tract Inf | 1984 |
[Oral antimycotic ketoconazole in the treatment of vaginal mycoses].
Topics: Administration, Oral; Balanitis; Candidiasis; Candidiasis, Vulvovaginal; Female; Humans; Ketoconazol | 1984 |
Toxic hepatitis following ketoconazole treatment.
Topics: Candidiasis; Chemical and Drug Induced Liver Injury; Female; Humans; Ketoconazole; Middle Aged | 1984 |
Hematogenous Candida spondylitis. A case report.
Topics: Amphotericin B; Candidiasis; Clindamycin; Drug Therapy, Combination; Female; Flucytosine; Humans; Ke | 1984 |
Efficacy of antifungal agents in the cornea. II. Influence of corticosteroids.
Topics: Adrenal Cortex Hormones; Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; | 1984 |
Assessing response to therapy for mucosal candidiasis.
Topics: Candida albicans; Candidiasis; Candidiasis, Oral; Candidiasis, Vulvovaginal; Female; Humans; Ketocon | 1984 |
Ketoconazole for treatment of Candida arthritis.
Topics: Abscess; Adult; Arthritis, Infectious; Candidiasis; Female; Humans; Ketoconazole; Pregnancy; Puerper | 1984 |
[Correlation of in vitro and in vivo actions of azole antimycotics].
Topics: Animals; Antifungal Agents; Candidiasis; Flucytosine; In Vitro Techniques; Ketoconazole; Male; Mice; | 1984 |
[Treatment of superficial mycoses].
Topics: Administration, Topical; Antifungal Agents; Candidiasis; Dermatomycoses; Female; Griseofulvin; Human | 1984 |
Ketoconazole treatment of fungal infection in acute renal failure.
Topics: Acute Kidney Injury; Candidiasis; Diabetic Nephropathies; Humans; Ketoconazole; Kinetics; Male; Midd | 1983 |
Evaluation of auto-antibodies in chronic mucocutaneous candidiasis without endocrinopathy.
Topics: Adolescent; Adult; Antibodies, Antinuclear; Antibodies, Fungal; Antibody Formation; Autoantibodies; | 1984 |
Influence of the corneal epithelium on the efficacy of topical antifungal agents.
Topics: Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Candidiasis; Cornea; Corneal Di | 1984 |
Antimycotic activity of BAY N 7133 in animal experiments.
Topics: Administration, Oral; Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Aspergill | 1984 |
Oesophageal candidiasis and croup in a child with defective neutrophil motility.
Topics: Candidiasis; Chemotaxis, Leukocyte; Croup; Esophageal Diseases; Female; Humans; Immunologic Deficien | 1984 |
[Familial chronic mucocutaneous candidiasis. Study of 2 families].
Topics: Adolescent; Adult; Amphotericin B; Candidiasis; Candidiasis, Chronic Mucocutaneous; Consanguinity; F | 1984 |
[Monilial granuloma treated successfully with ketoconazole over a period of 30 months].
Topics: Adolescent; Candidiasis; Candidiasis, Chronic Mucocutaneous; Facial Dermatoses; Granuloma; Hand Derm | 1984 |
Increased resistance to antifungal antibiotics of Candida spp. adhered to silicone.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida; Candidiasis; Cell Adhesion; Drug Resistance, M | 1995 |
Successful antifungal prophylaxis in chronic peritoneal dialysis: a pediatric experience.
Topics: Anti-Bacterial Agents; Bacterial Infections; Candidiasis; Child; Gastrostomy; Humans; Jejunostomy; K | 1995 |
Esophageal candidiasis following omeprazole therapy: a report of two cases.
Topics: Abdominal Pain; Adolescent; Adult; Candidiasis; Esophageal Diseases; Female; Gastritis; Humans; Keto | 1995 |
Fungemia and colonization with nystatin-resistant Candida rugosa in a burn unit.
Topics: Amphotericin B; Burn Units; Burns; Candida; Candidiasis; Case-Control Studies; Cross Infection; Fluc | 1994 |
Candida nail bed infection and cosmetic acrylic nail extensions--a potential source of hospital infection?
Topics: Adult; Antifungal Agents; Candidiasis; Cosmetics; Cross Infection; Female; Humans; Itraconazole; Ket | 1993 |
Neonatal renal candidiasis.
Topics: Amphotericin B; Candidiasis; Diagnostic Imaging; Drug Therapy, Combination; Fluconazole; Humans; Inf | 1994 |
Candida zeylanoides causing candidiasis as tinea cruris.
Topics: Adult; Animals; Candida; Candidiasis; Culture Media; Female; Guinea Pigs; Humans; Ketoconazole; Male | 1993 |
Severe candidal infections in neutropenic patients.
Topics: Amphotericin B; Candidiasis; Fluconazole; Humans; Itraconazole; Ketoconazole; Neutropenia | 1993 |
Insufficient ketoconazole concentrations in preterm infants with fungal infections.
Topics: Candidiasis; Drug Administration Schedule; Female; Humans; Infant; Infant, Newborn; Infant, Prematur | 1993 |
Cost-effective treatment of Candida esophagitis.
Topics: Candidiasis; Esophagitis; Fluconazole; Humans; Ketoconazole | 1993 |
Asymptomatic amniotic fluid invasion with Candida albicans in preterm premature rupture of membranes. Implications for obstetric and neonatal management.
Topics: Adult; Amniotic Fluid; Amphotericin B; Candida albicans; Candidiasis; Chorioamnionitis; Female; Feta | 1993 |
Cost-effective treatment of Candida esophagitis.
Topics: AIDS-Related Opportunistic Infections; Candidiasis; Esophagitis; Humans; Ketoconazole | 1993 |
Cost-effective treatment of Candida esophagitis.
Topics: Candidiasis; Esophagitis; Fluconazole; Humans; Ketoconazole | 1993 |
Cost-effective treatment of Candida esophagitis.
Topics: Candidiasis; Drug Costs; Esophagitis; Fluconazole; Humans; Ketoconazole | 1993 |
[Ketoconazole and dexamethasone suppression tests].
Topics: Aged; Aged, 80 and over; Candidiasis; Cushing Syndrome; Dexamethasone; Drug Interactions; Humans; Hy | 1993 |
Azole drug resistance in yeasts.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Candidiasis; Drug Resistance, Micr | 1995 |
Changing pattern of Candida species in a bone marrow transplant patient.
Topics: Adult; Antifungal Agents; Bone Marrow Transplantation; Candidiasis; Drug Resistance, Microbial; Fung | 1996 |
Lichen planus esophagitis with secondary candidiasis: successful combination treatment with ketoconazole and a corticosteroid.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Candidiasis; Drug Therapy, Combination; | 1996 |
[Clinical fluconazole and itraconazole resistance of oro-gastrointestinal candidiasis in a patient with AIDS].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida albicans; C | 1996 |
In vitro synergistic activity of ketoconazole with valproic acid against Candida species.
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis; Drug Synergism; Humans; Ketoconazole; Mic | 1996 |
Rationalizing prescribing for oral and oesophageal candidiasis.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Candidiasis, Oral; Drug Costs | 1996 |
Chronic Candida albicans otitis media in children with immunodeficiency.
Topics: Antifungal Agents; Candidiasis; Child; Child, Preschool; Chronic Disease; Diagnosis, Differential; F | 1997 |
Systemic antifungal drugs.
Topics: Amphotericin B; Anorexia; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Coccidioidom | 1997 |
[In vitro susceptibility to antifungal agents of Candida strains isolated from patients with various diseases of the respiratory tract].
Topics: Adult; Aged; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Flucona | 1997 |
Candida infection after total knee arthroplasty. Management without resection or amphotericin B.
Topics: Aged; Antifungal Agents; Arthroplasty, Replacement, Knee; Candidiasis; Female; Humans; Ketoconazole; | 1997 |
Clinical predictors of azole resistance, outcome and survival from oesophageal candidiasis in AIDS patients.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Body Weight; Candidiasis; CD4 Lymphocyte C | 1998 |
Antifungal susceptibility of Candida isolates at the American University of Beirut Medical Center.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis; Fluconazole; Flucytosine; | 1998 |
Trends in antifungal use and epidemiology of nosocomial yeast infections in a university hospital.
Topics: Adult; Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Candidiasis; Cross Infection; | 1999 |
In-vitro resistance to azoles associated with mitochondrial DNA deficiency in Candida glabrata.
Topics: Antifungal Agents; Azoles; Candida; Candidiasis; Clotrimazole; DNA, Fungal; DNA, Mitochondrial; Drug | 1999 |
[Epidemiology of fungemia in a university hospital; therapeutic incidence].
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Child, Pres | 1999 |
Breakthrough Candida tropicalis fungemia during ketoconazole prophylaxis in cancer patients.
Topics: Adult; Antibiotic Prophylaxis; Antifungal Agents; Candida; Candidiasis; Child; Female; Fungemia; Hum | 1999 |
Clinical management of tacrolimus drug interactions in renal transplant patients.
Topics: Adult; Aged; Antifungal Agents; Candidiasis; Drug Interactions; Erythromycin; Female; Humans; Immuno | 1999 |
Prospective study on fungemia in children with cancer: analysis of 35 cases and comparison with 130 fungemias in adults.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Antifungal Agents; Candida albicans; Candidiasis; Child; | 2000 |
Susceptibility testing of Candida species: comparison of NCCLS microdilution method with Fungitest.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Fluconazole; Fl | 2000 |
The combination of oral amphotericin B with azoles prevents the emergence of resistant Candida species in neutropenic patients.
Topics: Amphotericin B; Antifungal Agents; Azoles; Bone Marrow Transplantation; Candida; Candidiasis; Drug R | 2001 |
Influence of pH and concentration on the postantifungal effect and on the effects of sub-MIC concentrations of 4 antifungal agents on previously treated Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucy | 2000 |
Effect of ketoconazole, itraconazole and fluconazole on the gastrointestinal colonization of mice by Candida albicans.
Topics: Animals; Antifungal Agents; Azoles; Candida albicans; Candidiasis; Digestive System; Fluconazole; It | 2001 |
Oropharyngeal candidiasis in patients with human immunodeficiency virus: correlation of clinical outcome with in vitro resistance, serum azole levels, and immunosuppression.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Child; Dru | 2001 |
[Identification and antifungal susceptibility of Candida spp isolated from invasive mycoses. Influence of growth inhibition percentage to determine minimal inhibitory concentration].
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Child; Fluconazole; Growth Inhibitor | 2002 |
Fluconazole and ketoconazole in the treatment of oral and esophageal candidiasis in AIDS patients.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Candidiasis; Candidiasis, Oral; Esophageal Disea | 1992 |
Oral itraconazole therapy for disseminated candidiasis in low birth weight infants.
Topics: Administration, Oral; Antifungal Agents; Candidiasis; Humans; Infant, Newborn; Infant, Premature, Di | 1992 |
[New treatments of onychomycoses].
Topics: Administration, Topical; Antifungal Agents; Candidiasis; Ciclopirox; Fluconazole; Foot Dermatoses; H | 1992 |
In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy | 1992 |
Itraconazole therapy for disseminated candidiasis in a very low birthweight neonate.
Topics: Administration, Oral; Antifungal Agents; Candidiasis; Humans; Infant, Low Birth Weight; Infant, Newb | 1992 |
Treatment of neonatal Candida albicans septicemia with itraconazole.
Topics: Antifungal Agents; Candidiasis; Fungemia; Humans; Infant, Newborn; Itraconazole; Ketoconazole; Male | 1992 |
Ventriculitis and hydrocephalus caused by Candida albicans successfully treated by antimycotic therapy and cerebrospinal fluid shunting.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Brain Abscess; Candidiasis; Cerebral Ventricles; Cere | 1992 |
Fungus ball: a cause of early obstructive uropathy in renal transplantation.
Topics: Candidiasis; Female; Humans; Ketoconazole; Kidney Transplantation; Postoperative Complications; Uret | 1992 |
The identification and tracking of Candida albicans isolates from oral lesions in HIV-seropositive individuals.
Topics: AIDS-Related Opportunistic Infections; Blotting, Southern; Candida albicans; Candidiasis; DNA, Funga | 1992 |
Fungal keratitis after radial keratotomy.
Topics: Adult; Amphotericin B; Candidiasis; Eye Infections, Fungal; Female; Humans; Keratitis; Keratotomy, R | 1992 |
Acute renal failure after liver transplantation in patients treated with cyclosporine.
Topics: Acute Kidney Injury; Adult; Candidiasis; Cyclosporine; Female; Humans; Ketoconazole; Liver Cirrhosis | 1992 |
Candida laryngotracheitis: a complication of combined steroid and antibiotic usage in croup.
Topics: Amphotericin B; Candidiasis; Candidiasis, Oral; Cefaclor; Cefuroxime; Croup; Dexamethasone; Female; | 1992 |
Comparison of SCH 39304, fluconazole, and ketoconazole for treatment of systemic infections in mice.
Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Drug Evaluation, Precl | 1992 |
[Esophageal candidiasis in patients with hemoblastosis].
Topics: Candidiasis; Diagnosis, Differential; Esophageal Diseases; Female; Humans; Ketoconazole; Leukemia, M | 1992 |
Favorable outcome with ketoconazole in Candida septic arthritis.
Topics: Adult; Arthritis, Infectious; Candida albicans; Candidiasis; Female; Humans; Ketoconazole; Knee Join | 1992 |
[Mycoses as opportunistic infections in AIDS patients].
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; H | 1991 |
[Meningitis caused by Candida albicans in a male patient infected by HIV and failure of treatment with amphotericin B].
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Candidiasis; Drug Therapy, Combination; F | 1991 |
[In vivo and in vitro antifungal activity of fluconazole].
Topics: Animals; Aspergillus; Candida albicans; Candidiasis; Cryptococcus; Drug Resistance, Microbial; Fluco | 1991 |
[Bilateral Torulopsis glabrata pneumonia].
Topics: Candidiasis; Humans; Ketoconazole; Lung Diseases, Fungal; Male; Middle Aged; Pneumonia; Tomography, | 1991 |
Effects of pentamidine alone and in combination with ketoconazole or itraconazole on the growth of Candida albicans.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistanc | 1990 |
[Candida albicans infection in Japanese nightingales: diagnosis therapy and supplementary measures].
Topics: Animals; Bird Diseases; Birds; Candidiasis; Female; Ketoconazole; Male | 1991 |
Discovering antimycotic drugs: today and tomorrow.
Topics: Antifungal Agents; Azoles; Candidiasis; Dermatomycoses; Female; Humans; Itraconazole; Ketoconazole; | 1990 |
Evaluation of Bay R 3783 in rodent models of superficial and systemic candidiasis, meningeal cryptococcosis, and pulmonary aspergillosis.
Topics: Administration, Oral; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Crypto | 1990 |
Endogenous Candida endophthalmitis. Management without intravenous amphotericin B.
Topics: Adult; Aged; Amphotericin B; Candida; Candida albicans; Candidiasis; Endophthalmitis; Eye Infections | 1990 |
Chronic mucocutaneous candidiasis in childhood and complications of non-Candida infection: a report of the Pediatric Immunodeficiency Collaborative Study Group.
Topics: Adolescent; Amphotericin B; Autoimmune Diseases; Candidiasis; Candidiasis, Chronic Mucocutaneous; Ch | 1990 |
Otitic candidiasis in children: an evaluation of the problem and effectiveness of ketoconazole in 10 patients.
Topics: Candidiasis; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Ketoconazole; Male; Otitis M | 1990 |
Immunological studies in chronic mucocutaneous candidiasis before and after ketoconazole treatment.
Topics: Adolescent; Adult; Antigen-Antibody Complex; Candidiasis; Candidiasis, Chronic Mucocutaneous; Child; | 1987 |
Influence of the immunostimulating substance tiprotimod on Candida albicans infection in relation to activation of macrophages.
Topics: Adjuvants, Immunologic; Animals; Candidiasis; Dextran Sulfate; Dextrans; Drug Therapy, Combination; | 1989 |
Aneurysm associated with chronic mucocutaneous candidiasis during long-term therapy with ketoconazole.
Topics: Adult; Aneurysm, Infected; Candidiasis; Candidiasis, Chronic Mucocutaneous; Dose-Response Relationsh | 1989 |
Prevalence and clinical spectrum of skin disease in patients infected with human immunodeficiency virus.
Topics: Adult; Candidiasis; Dermatitis, Seborrheic; HIV Seropositivity; Homosexuality; Humans; Injections, I | 1989 |
Comparison of the efficacies of amphotericin B, fluconazole, and itraconazole against a systemic Candida albicans infection in normal and neutropenic mice.
Topics: Agranulocytosis; Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Fluconaz | 1989 |
New triazole antifungal agents (fluconazole and itraconazole) in the treatment of HIV-related gastrointestinal candidiasis.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Candidiasis; Fluconazole; Gastrointestinal Di | 1989 |
Use of itraconazole in a patient with chronic mucocutaneous candidiasis.
Topics: Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Child; Humans; Itraconazole; Ket | 1989 |
Severe clinical manifestations of primary HIV infection.
Topics: Adult; Candidiasis; CD4-Positive T-Lymphocytes; Esophageal Diseases; HIV Infections; Humans; Ketocon | 1989 |
[Candida meningitis in a human immunodeficiency virus seropositive woman].
Topics: Adult; Amphotericin B; Candidiasis; Female; HIV Seropositivity; Humans; Ketoconazole; Meningitis | 1989 |
[Infections caused by Candida krusei in newborn infants].
Topics: Antifungal Agents; Candida; Candidiasis; Drug Therapy, Combination; Flucytosine; Humans; Infant, New | 1989 |
[Candida fungemia].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Blood; Candida albicans; Candidiasis; Ch | 1989 |
Transient increase in plasma quinidine concentrations during ketoconazole-quinidine therapy.
Topics: Aged; Candidiasis; Creatinine; Digoxin; Drug Interactions; Humans; Ketoconazole; Leukemia, Myeloid, | 1989 |
Oral ketoconazole and flucytosine for neonatal systemic candidiasis.
Topics: Administration, Oral; Candidiasis; Drug Therapy, Combination; Flucytosine; Humans; Infant, Newborn; | 1989 |
Ketoconazole in the treatment of osteomyelitis due to Candida albicans.
Topics: Candidiasis; Child, Preschool; Finger Injuries; Humans; Ketoconazole; Male; Osteomyelitis; Radiograp | 1989 |
The use of ketoconazole in prophylaxis of Candida sepsis.
Topics: Animals; Candidiasis; Disease Models, Animal; Guinea Pigs; Hydrogen-Ion Concentration; Ketoconazole; | 1989 |
Vibratory urticaria associated with bladder-wall infection with the yeast Torulopsis glabrata.
Topics: Candidiasis; Female; Humans; Hydroxyzine; Ketoconazole; Middle Aged; Occupational Diseases; Urinary | 1989 |
Ketoconazole resistance in Torulopsis glabrata.
Topics: Animals; Candida; Candidiasis; Disease Models, Animal; Drug Resistance, Microbial; Humans; Immunosup | 1989 |
Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy | 1987 |
[Anti-Candida activity of azoles].
Topics: Animals; Antifungal Agents; Azoles; Candida; Candidiasis; Drug Evaluation, Preclinical; Female; Guin | 1987 |
Activities of fluconazole (UK 49,858) and ketoconazole against ketoconazole-susceptible and -resistant Candida albicans.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Microbial; Fluconazole; | 1988 |
[The pregnant woman infected with the human immunodeficiency virus: recommendations for her management].
Topics: Acquired Immunodeficiency Syndrome; Candidiasis; Cytomegalovirus Infections; Female; Humans; Ketocon | 1988 |
Use of fluconazole in a patient with documented malabsorption of ketoconazole.
Topics: Administration, Oral; Adult; Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Fem | 1988 |
[Candida spondylodiscitis treated with itraconazole].
Topics: Adolescent; Antifungal Agents; Candidiasis; Discitis; Humans; Immunologic Deficiency Syndromes; Itra | 1988 |
Intervertebral diskitis due to Candida tropicalis.
Topics: Aged; Aged, 80 and over; Candidiasis; Discitis; Humans; Ketoconazole; Male | 1989 |
Comparison of benefit against risk of ketoconazole therapy.
Topics: Adult; Aged; Candidiasis; Chemical and Drug Induced Liver Injury; Clinical Enzyme Tests; Dermatomyco | 1986 |
Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytes.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Candidiasis, Vulvovaginal; Dermatomycoses; | 1985 |
Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Female; Fluconazole; Immune Tolerance; Inte | 1985 |
Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits.
Topics: Animals; Candidiasis; Cortisone; Cryptococcosis; Dose-Response Relationship, Drug; Fluconazole; Immu | 1986 |
Azole resistance in Candida albicans.
Topics: Adult; Animals; Antifungal Agents; Candida albicans; Candidiasis; Candidiasis, Chronic Mucocutaneous | 1986 |
Therapeutic efficacy of itraconazole in systemic candidosis in guinea pigs.
Topics: Animals; Antifungal Agents; Basophils; Candidiasis; Drug Administration Schedule; Eosinophils; Guine | 1987 |
Penetration of new azole compounds into the eye and efficacy in experimental Candida endophthalmitis.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Endophthalmitis; Eye; Fluconazole; Itraco | 1987 |
Itraconazole treatment of experimental systemic candidiasis in male rats.
Topics: Animals; Antifungal Agents; Candidiasis; Dose-Response Relationship, Drug; Itraconazole; Ketoconazol | 1987 |
[Chronic mucocutaneous candidiasis].
Topics: Adult; Candidiasis; Candidiasis, Chronic Mucocutaneous; Child; Cimetidine; Drug Therapy, Combination | 1988 |
Hypothyroidism after treatment with ketoconazole.
Topics: Candidiasis; Candidiasis, Chronic Mucocutaneous; Humans; Hypothyroidism; Ketoconazole; Male | 1987 |
[Incidence of mycotic infections in children with acute myeloblastic leukemia (AML)].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Child; Clotrimazole; Drug Resistance, Micro | 1988 |
Esophageal candidiasis.
Topics: Amphotericin B; Autoimmune Diseases; Candidiasis; Esophageal Diseases; Esophagoscopy; Female; Humans | 1988 |
Candidal epididymitis treated with ketoconazole.
Topics: Candidiasis; Epididymitis; HIV Seropositivity; Humans; Ketoconazole; Male; Middle Aged | 1988 |
Candida albicans corpora abscess following penile prosthesis placement.
Topics: Abscess; Amphotericin B; Candidiasis; Combined Modality Therapy; Drug Therapy, Combination; Erectile | 1988 |
Folliculitis caused by Candida parapsilosis.
Topics: Candidiasis; Folliculitis; Humans; Ketoconazole; Male; Miconazole; Middle Aged | 1988 |
Usefulness of ketoconazole (Nizoral) in the treatment of androgenization symptoms in women suffering concurrently from candidiasis or dermatomycosis.
Topics: Adolescent; Adult; Androgens; Candidiasis; Dermatomycoses; Female; Humans; Ketoconazole; Virilism | 1988 |
[Efficacy of ketoconazole in the treatment of systemic candidiasis with pulmonary involvement].
Topics: Aged; Candidiasis; Humans; Ketoconazole; Lung Diseases, Fungal; Male | 1988 |
Emphysematous prostatitis and cystitis secondary to Candida albicans.
Topics: Amphotericin B; Candidiasis; Cystitis; Emphysema; Humans; Ketoconazole; Male; Middle Aged; Prostatit | 1988 |
Evaluation of single-drug and combination antifungal therapy in an experimental model of candidiasis in rabbits with prolonged neutropenia.
Topics: Agranulocytosis; Amphotericin B; Animals; Antifungal Agents; Candidiasis; Cytarabine; Drug Evaluatio | 1988 |
Candida esophagitis in patients infected by human immune deficiency virus: treatment and prognostic significance.
Topics: Acquired Immunodeficiency Syndrome; Candidiasis; Esophagitis; Humans; Ketoconazole; Prognosis | 1988 |
[Role of invasive candidiasis in hospital pathology].
Topics: Adolescent; Adult; Aged; Amphotericin B; Blood; Candidiasis; Child; Child, Preschool; Cross Infectio | 1987 |
Use of ketoconazole in urogenital blastomycetic processes.
Topics: Adult; Candidiasis; Cystitis; Female; Humans; Ketoconazole; Male; Prostatitis; Urethritis; Urologic | 1987 |
Treatment of blastomycetes induced chronic prostatitis with ketoconazole (Nizoral).
Topics: Adult; Candidiasis; Chronic Disease; Humans; Ketoconazole; Male; Middle Aged; Prostatitis | 1987 |
Hepatic candidiasis: an increasing problem in immunocompromised patients.
Topics: Adult; Amphotericin B; Biopsy; Candida; Candidiasis; Drug Therapy, Combination; Female; Flucytosine; | 1987 |
Refractory esophageal candidiasis associated with a low molecular weight plasma inhibitor of T-lymphocyte function.
Topics: Adult; Candidiasis; Esophageal Diseases; Female; Humans; Immunologic Deficiency Syndromes; Interleuk | 1986 |
Oral ketoconazole and intraocular amphotericin B for treatment of postoperative Candida parapsilosis endophthalmitis.
Topics: Administration, Oral; Aged; Aged, 80 and over; Amphotericin B; Candidiasis; Cataract Extraction; Dru | 1987 |
An outbreak of Candida parapsilosis endophthalmitis: analysis of strains by enzyme profile and antifungal susceptibility.
Topics: Amphotericin B; Candida; Candidiasis; Disease Outbreaks; Drug Contamination; Endophthalmitis; Flucyt | 1987 |
The place of elective vitrectomy in the management of patients with Candida endophthalmitis.
Topics: Amphotericin B; Candidiasis; Endophthalmitis; Female; Flucytosine; Follow-Up Studies; Humans; Ketoco | 1987 |
Experimental study of the intra-ocular penetration of ketoconazole in rabbits.
Topics: Animals; Aqueous Humor; Candidiasis; Endophthalmitis; Eye; Female; Ketoconazole; Male; Rabbits; Tear | 1987 |
Ketoconazole-resistant Candida esophagitis in patients with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Candida albicans; Candidiasis; Drug Resistance, Microbial | 1986 |
Tricuspid valve Candida endocarditis. Successful treatment with valve-sparing debridement and antifungal chemotherapy in a multiorgan transplant recipient.
Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis; Combined Modality Therapy; Debridement; Endoc | 1986 |
The influence of antifungal drugs on adherence of Candida albicans to buccal epithelial cells.
Topics: Adhesiveness; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Cheek; Dose-Response | 1986 |
Ketoconazole treatment of chronic mucocutaneous candidiasis.
Topics: Adolescent; Adult; Aged; Candidiasis; Candidiasis, Chronic Mucocutaneous; Child; Drug Administration | 1986 |
Ketoconazole and flucytosine alone and in combination against Candida spp. in a neutropenic site in rabbits.
Topics: Animals; Candida; Candida albicans; Candidiasis; Drug Synergism; Drug Therapy, Combination; Flucytos | 1986 |
[Chronic mucocutaneous candidiasis. Cutaneous expression of immunologic anomalies. Report of a case].
Topics: Candidiasis; Candidiasis, Chronic Mucocutaneous; Child; Female; Humans; Immunity, Cellular; Ketocona | 1986 |
Candida albicans endophthalmitis following penetrating keratoplasty.
Topics: Administration, Oral; Candidiasis; Corneal Transplantation; Endophthalmitis; Humans; Ketoconazole; M | 1987 |
The serological response to Candida albicans in leukemic patients prophylactically treated with ketoconazole.
Topics: Adolescent; Adult; Aged; Antibodies, Fungal; Candida albicans; Candidiasis; Female; Humans; Immunogl | 1987 |
[2 cases of Candida chorioretinitis in heroin addicts: value of the treatment with ketoconazole].
Topics: Adult; Candidiasis; Chorioretinitis; Female; Heroin Dependence; Humans; Ketoconazole; Male; Prognosi | 1987 |
Disseminated histoplasmosis in two patients with chronic mucocutaneous candidiasis.
Topics: Adult; Amphotericin B; Candidiasis; Candidiasis, Chronic Mucocutaneous; Child; Female; Histoplasmosi | 1987 |
Candida folliculitis in heroin addicts.
Topics: Adult; Candidiasis; Female; Folliculitis; Heroin Dependence; Humans; Ketoconazole; Male | 1986 |
Candidal costochondritis responsive to ketoconazole in an iv drug abuser.
Topics: Adolescent; Candidiasis; Female; Heroin Dependence; Humans; Ketoconazole; Osteochondritis; Ribs | 1986 |
Disseminated candidiasis in heroin addicts. Report of two cases and review of the literature.
Topics: Adult; Candidiasis; Heroin Dependence; Humans; Ketoconazole; Male; Sepsis | 1986 |
Ketoconazole and the yeast connection.
Topics: Candidiasis; Female; Humans; Ketoconazole | 1986 |
Treatment with ketoconazole in diabetic patients with vaginal candidiasis.
Topics: Administration, Oral; Adult; Candidiasis; Candidiasis, Chronic Mucocutaneous; Diabetes Complications | 1986 |
A note on the experimental uptake and clearance of Candida albicans in a young captive gull (Larus sp.).
Topics: Animals; Bird Diseases; Birds; Candidiasis; Carrier State; Feces; Ketoconazole; Water Microbiology | 1986 |
Treatment of superficial fungal infections.
Topics: Administration, Oral; Candidiasis; Dermatomycoses; Griseofulvin; Humans; Ketoconazole; Pityriasis; T | 1986 |
Topical ketoconazole for experimental Candida keratitis in rabbits.
Topics: Administration, Topical; Animals; Candidiasis; Keratitis; Ketoconazole; Ointments; Rabbits | 1986 |
Microtiter broth dilution method for yeast susceptibility testing with validation by clinical outcome.
Topics: Amphotericin B; Animals; Candida; Candidiasis; Culture Media; Flucytosine; Humans; Ketoconazole; Mic | 1986 |
Activity of SM-4470, a new imidazole derivative, against experimental fungal infections.
Topics: Animals; Antifungal Agents; Aspergillosis; Candidiasis; Candidiasis, Vulvovaginal; Female; Guinea Pi | 1986 |
[Chronic mucocutaneous candidiasis].
Topics: Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Female; Humans; Ketoconazole; Mi | 1986 |
Candida tropicalis papillary necrosis treated with ketoconazole.
Topics: Adult; Candidiasis; Diabetes Mellitus, Type 1; Humans; Ketoconazole; Kidney Papillary Necrosis; Male | 1985 |
Antifungal agents.
Topics: Antifungal Agents; Candidiasis; Dermatomycoses; Drug Therapy, Combination; Humans; Imidazoles; Ketoc | 1985 |
Chronic mucocutaneous candidiasis treated with ketoconazole (Nizoral).
Topics: Candidiasis; Candidiasis, Chronic Mucocutaneous; Candidiasis, Oral; Child; Facial Dermatoses; Humans | 1985 |
Histoplasmosis in the acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Candidiasis; Female; Herpes Simplex; Hist | 1985 |
Candidal endophthalmitis in Glaswegian heroin addicts: report of an epidemic.
Topics: Adolescent; Adult; Amphotericin B; Candidiasis; Disease Outbreaks; Endophthalmitis; Female; Fundus O | 1985 |
[Heterosexual transmission of the acquired immunodeficiency syndrome (AIDS)].
Topics: Acquired Immunodeficiency Syndrome; Adult; Bone Marrow Examination; Bronchi; Candidiasis; Cerebral I | 1985 |
[Treatment Candida albicans endophthalmitis with ketoconazole].
Topics: Amphotericin B; Candidiasis; Endophthalmitis; Flucytosine; Humans; Ketoconazole | 1985 |
Cutaneous, ocular, and osteoarticular candidiasis in heroin addicts: new clinical and therapeutic aspects in 38 patients.
Topics: Adult; Aged; Amphotericin B; Bone Diseases; Candida albicans; Candidiasis; Candidiasis, Cutaneous; E | 1985 |
Oropharyngeal Candida prophylaxis in pediatric bone marrow transplant patients.
Topics: Adolescent; Anemia, Aplastic; Bone Marrow Transplantation; Burkitt Lymphoma; Candidiasis; Child; Chi | 1985 |
Treatment of systemic candidiasis in neutropenic dogs with ketoconazole.
Topics: Agranulocytosis; Animals; Bone Marrow; Bone Marrow Transplantation; Candida albicans; Candidiasis; D | 1985 |
Correlation of susceptibility test results in vitro with response in vivo: ketoconazole therapy in a systemic candidiasis model.
Topics: Animals; Candida albicans; Candidiasis; Culture Media; Ketoconazole; Male; Mice; Microbial Sensitivi | 1985 |
Ketoconazole: a reappraisal.
Topics: Adult; Candidiasis; Chemical and Drug Induced Liver Injury; Dermatomycoses; Female; Humans; Ketocona | 1985 |
Ketoconazole and the antifungals.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Humans; Ketocona | 1985 |
[Systemic candidiasis].
Topics: Amphotericin B; Candidiasis; Combined Modality Therapy; Female; Gestational Age; Humans; Infant; Inf | 1985 |
Control of an outbreak of systemic Candida albicans.
Topics: Antifungal Agents; Candidiasis; Cross Infection; Disease Outbreaks; Hand Disinfection; Humans; Ketoc | 1985 |
Laryngeal candidiasis and ketoconazole.
Topics: Candidiasis; Candidiasis, Chronic Mucocutaneous; Female; Humans; Ketoconazole; Laryngeal Diseases; M | 1985 |
An animal model for fungal peritonitis: evaluation of therapeutic options.
Topics: Administration, Oral; Animals; Candidiasis; Catheters, Indwelling; Disease Models, Animal; Drug Eval | 1986 |
Renal pelvocalyceal abscess secondary to Candida albicans.
Topics: Abscess; Candidiasis; Female; Humans; Ketoconazole; Kidney Diseases; Kidney Pelvis; Middle Aged | 1986 |
The "yeast connection" meets chronic mucocutaneous candidiasis.
Topics: Candidiasis; Candidiasis, Chronic Mucocutaneous; Child, Preschool; Humans; Ketoconazole; Male; Nysta | 1986 |
Do the imidazoles have a role in the management of genitourinary fungal infections?
Topics: Adult; Aged; Candidiasis; Clotrimazole; Female; Humans; Imidazoles; Ketoconazole; Male; Miconazole; | 1985 |
New azole compounds: vibunazole (Bay n7133) and Bay L9139, compared with ketoconazole in the therapy of systemic candidosis and in pharmacokinetic studies, in mice.
Topics: Animals; Antifungal Agents; Candidiasis; Imidazoles; Ketoconazole; Kinetics; Mice; Triazoles | 1985 |
Amphotericin B resistance in Candida.
Topics: Amphotericin B; Candidiasis; Drug Interactions; Drug Resistance, Microbial; Humans; Ketoconazole; Mi | 1985 |
Intraocular penetration of systemically administered antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cataract Extraction; Drug Contamination; Eye; Flucyt | 1985 |
[Prevention of mycoses caused by yeasts].
Topics: Candidiasis; Cryptococcosis; Disinfection; Humans; Infant; Infant, Newborn; Infant, Premature, Disea | 1985 |
[Report of a case of Yarrowia lipolytica (Wickerman et al.) van der Walt & von Arx isolated from a blood culture].
Topics: Blood; Candida; Candidiasis; Female; Humans; Ketoconazole; Middle Aged; Species Specificity | 1985 |
Statistical analysis for experimental models of ocular disease: continuous response measures.
Topics: Amphotericin B; Analysis of Variance; Animals; Candidiasis; Eye Diseases; In Vitro Techniques; Kerat | 1985 |
Disseminated candidiasis with extensive folliculitis in abusers of brown Iranian heroin.
Topics: Adult; Amphotericin B; Candidiasis; Conjunctivitis; Female; Flucytosine; Folliculitis; Heroin; Human | 1985 |
Oral treatment with ketoconazole in systemic candidosis of guinea-pigs: microbiology, hematology and histopathology.
Topics: Administration, Oral; Animals; Candidiasis; Eye; Guinea Pigs; Ketoconazole; Male; Skin | 1985 |
The effect of ketoconazole on Candida albicans infection following depression of the reticuloendothelial activity with gadolinium chloride.
Topics: Animals; Candidiasis; Gadolinium; Ketoconazole; Mice; Mice, Inbred Strains; Mononuclear Phagocyte Sy | 1985 |
Systemic candidiasis in drug addicts.
Topics: Adolescent; Adult; Candidiasis; Humans; Ketoconazole; Male; Substance-Related Disorders | 1985 |
Systemic candidiasis in premature infants experience with drug treatment.
Topics: Amphotericin B; Candidiasis; Cytosine; Drug Therapy, Combination; Flucytosine; Humans; Infant, Newbo | 1985 |
Isolated Candida arthritis: report of a case and definition of a distinct clinical syndrome.
Topics: Amphotericin B; Arthritis, Infectious; Candidiasis; Drug Therapy, Combination; Flucytosine; Humans; | 1985 |
Epidemic postsurgical Candida parapsilosis endophthalmitis. Clinical findings and management of 15 consecutive cases.
Topics: Aged; Amphotericin B; Candidiasis; Cataract Extraction; Eye Diseases; Female; Flucytosine; Humans; K | 1985 |